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ABSTRACT
Docosahexanoic acid (DHA) is an essential polyunsaturated fatty acid best-known as 
omega-3 fatty acid. DHA is a primary component of membrane phospholipids within 
the central nervous system with a major role in the development and function of the 
brain. Epidemiological studies have shown that people with low blood levels of omega-
3 fatty acids may be predisposed to neurological disorders including neurodegenerative 
diseases, depression and mood disorder. Neuronal apoptosis is considered as a key 
feature of neurodegenerative conditions of the brain.  Previous studies demonstrated that 
DHA supplementation could protect brain from apoptotic cell death and reduce the 
burden of the diseased state. From rodent study it was found that only small proportion 
of free fatty acid DHA orally administered to rodents reaches the brain because of the 
presence of Blood brain barrier (BBB) between blood and brain epithelial cells. Thus 
the delivery of DHA to the brain may contribute to poor neuronal health. The 
development of nanosized phospholipid liposomes, combined with strategies to target 
therapeutics to the blood brain barrier has enhanced the clinical utility of drug delivery 
systems.
DHA can be incorporated into membrane either as a free fatty acid (FFA) or 
incorporated into phosphatidylserine (PS), and phosphatidylethanolamine (PE) of 
neuronal membrane phospholipids (PLs) into brain. The aim of the study was to confirm
the anti-apoptotic effects of free fatty acid DHA (DHA-FFA) with other forms of DHA 
including DHA phospholipids (DHA-PLs) and DHA incorporated in nanoliposomes 
derived from milk fat globule membrane (MFGM) and soy, using cultured human 
neuronal like cells (NT2). In this thesis, different forms of DHA was examined in the 
prevention of neuronal cell death induced by two apoptotic inducing agents, 
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staurosporine (STS) and hydrogen peroxide (H2O2) in the NT2 cell model. Two
different treatment paradigms, widely used pre-treatment of cells with apoptotic 
inducing agents and an alternative co-treatment method also examined to assess the
differential effects of all these forms of DHA in protecting neuronal cells from 
apoptosis. Additionally, lipidomic experiments of DHA-FFA and DHA-PLs treated 
NT2 cells as well as DHA-nanoliposomes in both treatment paradigms were also carried 
out to explore the incorporation of treated DHA into particular lipid species in the 
cultured cells in normal and apoptotic environment.
It was found that DHA-FFA and DHA-PLs had a preventive effect against neuronal cell 
death, decreasing in cell death and reducing expression of the pro-apoptotic marker 
protein BAX in cultures exposed to the apoptotic agents STS and H2O2, in both co and 
pre-treatment paradigm. DHA-FFA was consistently more effective than DHA-PLs, 
which may relate to the differences in transport of the DHA species across the plasma 
membrane. Lipidomics results showed a significant difference in the changes of lipid 
classes between treatment with DHA-FFA and DHA-PLs. Overall, there was an 
increase in DHA containing phosphatidylinositol and phosphatidylcholine species.
The effects of different omega-3 fatty acids including DPA and EPA on inhibition of 
apoptosis were measured and compared to DHA. All the fatty acids treatments were
able to increase cell viability and reduce cell death against neuronal cell death induced 
by STS and H2O2. Analysis of BAX expression revealed similar effects between the 
DHA, DPA and EPA, but the results showed but the results suffered from variability 
that limited the capacity of obtaining of reproducible results. Further studies should 
investigate the uptake of the three omega-3 fatty acids into these neuronal cells in order 
to examine if the FA are incorporated in original form or are further metabolized.
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In the liposomal DHA study, results showed that apart from MFGM the rest of DHA-
FFA, and DHA- nanoliposomes treatments used in this study were shown to have a 
potential inhibitory effect against neuronal cell death and successfully reflected the 
results explained above. MFGM showed variability in its effect, which limited the 
ability to examine if the effects were reproducible. Lipidomics study of DHA-FFA and 
DHA-nanoliposomes treated NT2 cells shown to have a huge change in large variety of 
molecular species of membrane PLs. including LPC, PC, PE and PI contents. Among 
the changes the highest increase was recorded for PI in all treatments and in both 
treatment paradigms. Differential effects on changing the PLs content in DHA-FFA 
versus DHA-nanoliposomes treatment were also observed. DHA-FFA treatment shown 
to have higher increase in PLs content than that of DHA-nanoliposomes. Probable 
reasons could be the differences in uptake mechanism of individual DHA-FFA and 
DHA-nanoliposomes. Uptake of nanoliposomal DHA much is slower than the free 
DHA because of the complex structure.
To investigate the effects of DHA in improving electrophysiological properties between 
neuronal cells, primary mouse cortical neurons were treated with free DHA using a 
microelectrode array (MEA). Analysis of the recorded signal from DHA-treated cortical 
neuron indicated that DHA stimulated electrical activity and improved communication 
between the neurons. 
Taken together, in all experimental setup, DHA-FFA, DHA PLs, omega-3 fatty acids, 
and nanoliposomal DHA treatments led to inhibit the apoptotic effects of STS and 
H2O2, in NT2 cell cultures. DHA also shown to increase the electro-physiological
activity in cultured mouse cortical neuron which is indicative as an alternative 
therapeutic approach for the prevention or treatment of neurodegenerative diseases in 
promoting and maintaining good health.
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BACKGROUND
1. OVERVIEW
Docosahexanoic acid (DHA) is the most abundant omega-3 (n-3) polyunsaturated fatty 
acid in the brain (Carrie et al., 2000; Connor. et al., 1990; Crawford et al., 1976;
Gomez-Pinilla, 2008; Kawakita et al., 2006) essential for its development and function
(Bazan, 2003; Calon et al., 2004; Horrocks & Farooqui, 2004; H. Y. Kim et al., 2011;
Zhao et al., 2011). A DHA-deficient diet is reported to reduce brain DHA levels and 
adversely effect on neuronal development, behavior learning and memory in animals
(Catalan et al., 2002; Haubner et al., 2002; Stonehouse et al., 2013; Suzuki et al., 2001;
Tassoni et al., 2008). DHA supplementation was found beneficial to improve brain 
function at a marginal rate in diseased brain conditions such as neurodegeneration, and 
depression (Crawford et al., 2009; Logan, 2004). The nervous system is the second most 
concentrated in lipid content (50-60% of its dry weight) after adipose tissue. Out of 
which 35-40% of the lipids in the adult brain are from polyunsaturated fatty acid family 
(Yehuda et al., 1999). However, animal studies revealed that a very low proportion of 
DHA is delivered to the brain compared to other tissues such as kidney, liver and heart 
(Fu & Sinclair, 2000; Graf et al., 2010). From animal study it was also hypothesized 
WKDW RQO\  RI WKH '+$ V\QWKHVL]HG E\ OLYHU IURP WKH GLHWDU\ IURP SUHFXUVRU Į-
linolenic acid (ALA) delivered to the brain (Rapoport & Igarashi, 2009). It was also 
observed from radiolabeled Į-linolenic acid (ALA) rich diet fed guinea pig that the
brain contained roughly 22-25% of the total DHA in the body, while approximately 
50% of the DHA being distributed in the muscle and adipose tissue (Fu et al., 2001). A
possible reason of decreased DHA in the brain is due to insufficient delivery DHA to 
the brain cells. Therefore it is of particular importance to find ways of delivering DHA 
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more effectively to the brain for improved specificity of DHA to brain cells, therefore 
provide effective treatment for neurological conditions and lessen the burden of disease.
One of the hallmarks of neurodegenerative disorders is progressive and irreversible loss 
of neuronal cells by apoptosis (Friedlander & Yuan, 1998; Kanazawa, 2001; Kermer et 
al., 2004; Mattson, 2000; Okouchi et al., 2007). It is well established in several in-vitro 
and in-vivo studies that DHA plays a major role in the inhibition of neuronal apoptosis.
In those experiments the protective effect of DHA against apoptotic cell death was 
shown to be mediated by the enhanced phosphatidylserine (PS) accumulation into 
neuronal membranes (Calderon & Kim, 2007; Kim. et al., 2001; Kim. et al., 2000) as 
well as involving several anti-apoptotic pathways such as AKT pathway (Cao et al., 
2005; S. J. Kim et al., 2010). The anti-apoptotic properties of DHA were also
demonstrated in staurosporine induced apoptotic mouse neuroblastoma cell Neuro-2A,
where the pro-apoptotic marker caspase-3 activity was shown to be inhibited by DHA 
supplementation (Akbar & Kim, 2002).
In addition to DHA, other n-3 PUFAs including docosapentaenoic acid (DPA) and 
eicosapentaenoic acid (EPA) are shown to have neuroprotective effect against apoptotic 
cell death in-vitro (Cutuli et al., 2014; Dyall, 2015; Fotuhi et al., 2009; Kim. et al., 
2001; Luchtman et al., 2013; D. S. Martin et al., 2002; Sinha et al., 2009). To determine 
whether the protective effect was unique for DHA enrichment, the effects of other fatty 
acids eg: [Arachidonic acid (AA) and oleic acid (OA)] along with staurosporine-
induced apoptosis was examined. Significant inhibition of caspase-3 activity was 
observed only in DHA-enriched cells but not in OA and AA-enriched cells (Akbar & 
Kim, 2002). Above stated experiments led to conduct a comparative study of n-3
PUFAs to describe the differential effects of these PUFAs in the inhibition of apoptosis 
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induced in NT2 cells. Morphology of the NT2 cell line is epithelial-like, but the 
phenotype can potentially change to neuronal and glial cells through differentiation 
(Langlois & Duval, 1997). Two well-known apoptosis inducing agents, staurosporine 
(STS) and hydrogen peroxide (H2O2) were utilized for inducing apoptosis in NT2 cells
STS is a non-selective protein kinase inhibitor that has been used extensively to induce 
apoptosis in neurons (McCarthy et al., 1997; Philpott et al., 1996; Wiesner & Dawson, 
1996) as well as a variety of non-neuronal cells (Deshmukh & Johnson, 2000; Koh et 
al., 1995; Yang et al., 2014) including lymphocytes (Suzuki. et al., 1995), tumor cell 
lines (Jacobsen et al., 1996; Jacobson et al., 1993) and some other primary cells 
(Jacobsen et al., 1996). The mechanism of apoptosis induction by STS may differ from 
cells types and concentration of STS (Deshmukh & Johnson, 2000).
H2O2 has also been shown to induce neuronal cell death in undifferentiated and 
differentiated neuronal cell lines through the induction of generation of reactive oxygen 
species (ROS) (Chen et al., 2009) subsequently results in cell damage (Clement et al., 
1998; Singh et al., 2007). H2O2 produced ROS (Giorgio et al., 2007) promote inducing
DNA damage and disruption of cell membrane (Rodriguez et al., 1997). ROS-induced 
apoptosis is a very well-known phenomenon in cellular function that has been studied in 
experimental models (Datta et al., 2002; Zuliani et al., 2005). Regarding transport, 
H2O2 can diffuse freely across cell membranes when added exogenously (Mao et al., 
2006) and trigger apoptosis at low concentration. On the other hand a high 
concentration of H2O2 may also cause necrosis (Hampton & Orrenius, 1997; Suhara et 
al., 1998).
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DHA-PLs especially PC-16:0-22:6 and PE-18:0-22:6 are commonly found in cellular 
phospholipid pool (Bell & Tocher, 1989; Farkas et al., 2000; Kakela et al., 2003;
Mitchell. et al., 2007; Mitchell. et al., 2010; Nealon et al., 2008). The PE di-DHA form 
(PE di-22:6) is an unusual form of PL that was introduced to the thesis to see if it is 
useful in delivering more DHA to the cell membrane. Inhibitory effects of these forms 
of DHA were confirmed utilizing a cell viability assay (trypan blue exclusion method), 
Propidium iodide (PI) stained toxicity assay and by measuring the expression of pro-
apoptotic marker BAX protein in DHA treated cells.
Propidium iodide (PI) is a dye that is unable to penetrate through membranes and 
generally excluded from viable cells leaving only dead cells stained. PI was used to 
evaluate that the cytotoxic effects of apoptotic agents occurred through DNA 
fragmentation (Jiang et al., 2016; Riccardi & Nicoletti, 2006). Moreover, the Bcl-2
family proteins are considered as the potent regulators of apoptosis (Adams & Cory, 
1998; Chipuk et al., 2012; Gross et al., 1999; Tait & Green, 2010). Anti-apoptotic B cell 
lymphoma 2 (BCL-2) and pro-apoptotic BCL-2-associated X protein (BAX) are the 
major apoptosis regulatory proteins (Alavian et al., 2011).
Nanoparticles are important molecules in the field of drug delivery research. Several 
nanotechnological advancement have been made to deliver novel therapeutics for CNS 
disorders as well as in cancer medicine (Diaz & Vivas-Mejia, 2013; Srikanth & 
Kessler, 2012). There are several nanocarriers that have been applied to deliver 
therapeutics for CNS diseases namely, Nanoliposomes, Nanomicelle, DNA 
nanoparticle, Aptamer, dendrimer, carbon nanotube, nanofibre and nanogels all of 
which are involved with carrying different target specific drugs (Srikanth & Kessler, 
2012). Among them nanoliposomes are advantageous over other nanocarriers for their 
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unique surface properties that can be adaptable for numerous modifications.
Nanoliposomes are nanosized non-toxic and biodegradable bilayered vesicles 
composed of various phospholipids (Malam et al., 2009; Pattni et al., 2015). Numerous 
nanoliposomal preparations with hydrophilic and hydrophobic drugs are currently 
being utilized in clinical trials (Elbayoumi & Torchilin, 2010; Mora et al., 2002) for 
efficient drug delivery into the brain (Vyas et al., 2008) having crossed the principal 
obstacle, blood brain barrier (BBB). Moreover, Nanoliposomes incorporated DHA was 
shown to increase neuronal cell survival by increasing membrane fluidity and 
processing of Amyloid precursor protein (APP) (Eckert et al., 2011).
Based on the above evidences it was assumed that DHA might be more effectively 
delivered to the brain packed in nanoliposomes compared to DHA-FFA. In this study,
two different nanoliposomes derived from milk fat globule membrane (MFGM) and soy 
was used because of their low toxicity to the cells to encapsulate DHA for measuring 
their efficacy for anti-apoptotic properties. To elucidate the effect of DHA treatment 
more into neuronal communication, a directional change was made into experiment 
combining mouse cortical neuron and a new modern in vitro microelectrode array 
(MEA) technique that has been widely adopted for recording signals from neurons
(Johnstone et al., 2010; Nam & Wheeler, 2011) to understand the fundamentals of 
neural network mechanisms in the brain (Makarova et al., 2011). Accurate detection and 
localizing signatures of neural activity waveforms are essential in understanding the 
functioning of neural networks (Biffi et al., 2010).
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2. FATTY ACIDS STRUCTURES AND CLASSIFICATION
Fatty acids (FA) are naturally occurring molecules consisting of a hydrocarbon chains 
with a methyl group (CH3DWRQHHQGRIWKHPROHFXOHWKDWLVGHVLJQDWHGDVRPHJDȦ
and a carboxyl group (COOH) at the other end (Figure 1) (Rustan & Drevon, 2005).
The carbon atom closest to the carboxyl group is termed as the Į carbon, and the 
IROORZLQJRQHLVWKHȕFDUERQ,QVWHDGRIWKH*UHHNµȦ¶ the letter ‘n’ is also often used 
to denote the position of the double bond closest to the methyl end (Fotuhi et al., 2009;
Lauritzen et al., 2001). Depending on the carbon number, fatty acids chain can vary in 
length from 2 to 30 or more. FA chain may contain one or more double bonds as well 
(Calder & Yaqoob, 2009).
Figure 1: General structure of fatty acids.
Classification of fatty acids is done according to the number of carbon atoms and the 
number of double bond between the hydrocarbons. Naturally occurring FA structures 
are outlined in Figure 2. Saturated FAs consisting only single bonds (no double bond/s) 
between carbon-carbon atoms and are fully saturated with hydrogen atoms. Palmitic 
acid and stearic acid are the main saturated fatty acids in the brain having 16 and 18 
carbons respectively with no double bond (Table 1). Unsaturated FAs may contain at 
least one (mono unsaturated, eg: oleic acid) or more double bonds (poly unsaturated) 
making the chain unsaturated. Depending on the possession of carbon atoms, poly 
unsaturated FAs are further classified as long chain (containing 12-22 carbon atoms) 
and very long chain (containing 22 or more carbon atoms) poly unsaturated FAs 
(PUFAs) (Mehta et al., 2009; Rustan & Drevon, 2005).
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Table 1: Structure of different unbranched fatty acids containing a methyl, a carboxyl end, 
different carbon number and double bonds. Figure adapted from (Bazinet & Laye, 2014)
In relation WR WKHSRVLWLRQRI WKHGRXEOHERQGRQ WKHPHWK\O WHUPLQDO ȦQ-) end, the 
38)$V DUH IXUWKHU FODVVLILHG PDLQO\ LQWR WZR IDPLOLHV Ȧ- DQG Ȧ-6. Neuronal cell 
membranes are unique in mammalian species having omega-6 arachidonic acid (ARA) 
DQG Ȧ-3 docosahexaenoic acid (DHA) as major PUFAs (Bazinet & Laye, 2014;
Crawford et al., 2009; Plourde & Cunnane, 2007). Linoleic acid (LNA), 
HLFRVDSHQWDHQRLF DFLG (3$ DQG Į-linolenic acid (ALA) also appear in much lower 
concentration to that of ARA and DHA (Bazinet & Laye, 2014).
3. DOCOSAHEXAENOIC ACID (DHA)
DHA is a polyunsaturated fatty acid (PUFA) (Connor et al., 2007) having 22 carbons 
with 6 double bonds (22:6n-3). It is a member of omega-3 fatty acid family (Bazan, 
2006; Horrocks & Farooqui, 2004).  DHA is a major constituent of neuronal membrane 
phospholipids in the central nervous system (CNS) (Connor. et al., 1990). Cell 
membranes are composed of a lipid bilayer of which the major constituent is 
phospholipids (PL), neutral lipids including cholesterol and glycolipids in the form of 
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glycosphingolipids (Bretscher & Raff, 1975). The lipids in the cell membrane are not 
uniform in mammalian cells. The proportion of PL types such as phosphatidylcholine 
(PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol 
(PI) can vary between cell membranes. (Daleke, 2007; Glomset, 2006). Ester bonds help 
DHA to attach to the larger phospholipid molecules within the membrane lipid bilayer 
and this special feature of DHA act as membrane’s building blocks (Kidd, 2007).
4. SOURCES OF DHA
Bodily synthesized essential omega-3 fatty acids especially DHA is not sufficient for 
the needs of the human body. Thus it must be obtained from dietary sources. Fish is a 
direct dietary source of DHA (Fotuhi et al., 2009). Cold-water oceanic fish oils are 
enriched in DHA (Franklin et al., 1999; Racine & Deckelbaum, 2007). Most of the 
DHA in fish and multi-cellular organisms with access to cold-water oceanic foods 
originates from photosynthetic and heterotrophic microalgae, and becomes increasingly 
concentrated in organisms the further they are up the food chain. DHA is also found in 
high concentrations in many species of marine algae (Racine & Deckelbaum, 2007).
The short-FKDLQȦ-IDWW\DFLGĮ-OLQROHQLFDFLGȦ-3) can be obtained from foods, 
including vegetable oils, soybeans, walnuts (Fotuhi et al., 2009), wheat germ, and 
human milk and then elongated and desaturated to form the long-FKDLQȦ-3 fatty acids, 
(3$Ȧ-DQG'+$Ȧ-,QKXPDQVĮ-linolenic acid is readily converted 
to EPA EXWRQO\D VPDOOSHUFHQWDJH LV FRQYHUWHG WR'+$'LHWV WKDWDUHKLJK LQȦ-6
polyunsaturated fatty acids e.g.; diets rich in corn, safflower, sunflower, and peanut oils, 
can attenuate the conversion of these longer-FKDLQ Ȧ-3 polyunsaturated fatty acids 
because the two classes of fatty acids compete for the same enzyme for desaturation.
The Į-linolenic acid (ALA; 18:3n 3), one of the n-3 polyunsaturated fatty acid (PUFA) 
LVGHVDWXUDWHGE\WKHHQ]\PHǻGHVDWXUDVHWKDWLQYROYHGDGGLWLRQRIRQHGRXEOHERQG
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1HZO\ V\QWKHVL]HG Qఇ LV IXUWKHU HORQJDWHG WR DUDFKLGRQLF DFLG Q  E\ WKH
HQ]\PHHORQJDVHǻGHVDWXUDVHHQ]\PHDQGȕ-oxidation play a vital role in the step for 
the synthesis of docosahexaenoic acid (DHA; 22:6n 3) in the peroxisome from 
docosapentaenoic acid n-3 (22:5n-3) and released in the blood circulation.  (Bazan et 
al., 2011; Bazinet & Laye, 2014; Calder & Yaqoob, 2009; Kidd, 2007; H. Y. Kim, 2007;
Tanaka et al., 2007). Simplified metabolic pathway for the n-3 PUFAs is illustrated in 
the Figure 2 bellow.
Figure 2: Metabolic pathway and synthesis of DHA in the liver. Figure adapted and modified 
from (Bazinet & Laye, 2014).
Page | 10  
 
In the past 20 years oils have been extracted from fish liver or the whole fish and from 
cultured marine algae. The oils are triglycerides (TG)-rich oils and the proportions of 
the EPA and the DHA in the oils varies according to the species of fish and source. 
Recently oil has been extracted from Krill that are harvested from Antarctic Ocean. This 
oil contains both triacylglycerol (TAG) and PL. EPA and DHA are found in both lipid 
types (Sinclair et al., 2002).
5. DHA DEFICIENCIES AND NEUROLOGICAL DISORDERS
'H¿FLHQF\ RI '+$ LV DVVRFLDWHG ZLWK PDQ\ GLVRUGHUV LQFOXGLQJ QHXURGHJHQHUDWLYH
disorders, heart, kidney, rheumatoid arthritis and cancer (Collins et al., 1971; Connor. et 
al., 1990; Marik & Varon, 2009). Histopathological studies showed that adult patients 
deficient in nutritional DHA have neuronal atrophy in the pre-frontal cortex, a region of 
the brain that is susceptible to degenerative changes (McNamara, 2010). A link between 
DHA and Alzheimer’s disease was established where Alzheimer’s disease patients had 
low levels of DHA (Tully et al., 2003) and a reduced amount of DHA was found in the 
phospholipids within the hippocampal area (Corrigan et al., 1998). Animals fed on 
DHA-deficient diets displayed learning and memory deficits (Crawford et al., 2009) and 
an increase in depressive and aggressive behavior (DeMar et al., 2006).
6. DHA SUPPLEMENTATION IN NEUROLOGICAL DISORDERS
Clinical trials indicate that dietary omega-3 fatty acids reduce the risk of depression and 
perhaps also bipolar disorder (Crawford et al., 2009; Stahl et al., 2008). DHA treatment 
VKRZQWRUHGXFHWKHSURGXFWLRQRI$ȕLQWKH$O]KHLPHU¶VGLVHDVHPRXVHPRGHO(Cole & 
Frautschy, 2010). Additionally experimental evidence shows that omega-3 fatty acids 
may provide protection from mild cognitive impairment, where 8 out of 10 recent trials 
reported reduced omega-3 fatty acid blood levels with cognitive decline (Cole & 
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Frautschy, 2010). DHA supplementation has been effective in reducing symptoms in 
some degenerative brain conditions including Alzheimer’s disease or dementia and
improve dementia rating scales, intelligence and visual acuity (Terano et al., 1999;
Weiser et al., 2016). Studies show that only 1% of orally ingested DHA reaches the 
brain within 24 hours of compared with other tissues (Graf et al., 2010).
Supplementation of cultured neuronal cells with DHA can increase neurite outgrowth 
where young or developing neurons tend to elongate in their axon and dendritic length 
to form a complex circuitry to maintaining the homeostasis of the central nervous 
system (Calderon. & Kim, 2004; Furuya et al., 2002; Laketa et al., 2007; Marszalek et 
al., 2004; Okuda et al., 1994). DHA supplementation was reported to significantly 
increase neurite outgrowth in several cell types such as PC12 and primary hippocampal 
cells. In addition, high levels of DHA are found in the growth cone during neurite 
outgrowth (R. E. Martin & Bazan, 1992) where they can be important especially for 
maximal neurite outgrowth during neurodevelopment. DHA is found in the neuronal 
dendrites in the adult brain. Efficient regeneration of axons and dendrites after neuronal 
injury is promoted by DHA (Valenzuela & Valenzuela, 2013). Attention deficit-
hyperactivity disorder (ADHD) is common psychiatric disorders in young children. 
Most prominent symptoms of ADHD are lack of attention, hyperactivity, and being 
highly impulsive in behavior. Several experiments on school children and randomly 
selected ADHD patient suggested that the severity of the symptoms can be reduced by 
dietary supplementation of n-3 PUFAs especially DHA which subsequently improve the 
learning capability and change in aggressive behavior (Belanger et al., 2009; Bos et al., 
2015). A large body of evidence demonstrated in preclinical trials on human showing 
possible important role of DHA to against the development of a variety of psychiatric 
and neurological disorders including Alzheimer Disease (AD). In these clinical trials a 
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group of patients with mild to moderate Alzheimer Disease were randomized and prone 
to double-blinded, placebo-controlled study. Patients were fed with omega-3 PUFAs 1.8 
g/day or olive oil as placebo control almost over 24 weeks. Better cognitive 
improvement were observed in the omega-3 PUFAs treatment group than those in the
placebo group. (Chiu et al., 2008; Freund-Levi et al., 2006; Kotani et al., 2006). Taken 
together, DHA is shown to have therapeutic properties in wide ranges of neurological 
conditions. 
7. DHA AND BRAIN FUNCTION
DHA constitutes approximately 30–40% of the phospholipids of the gray matter of 
cerebral cortex and found in abundant generally in synaptosomal membranes (Carrie et 
al., 2000; Gomez-Pinilla, 2008). Membrane phospholipid DHA promote the 
development and function of the CNS including modulation of cognitive function, 
learning, memory, neurotransmitter release, cellular apoptosis and immunity and 
inflammation which are the integral part of healthy brain (Horrocks & Farooqui, 2004).
DHA is also associated with the formation of synapses between neurons in the nervous 
system, enhancement of memory, neuroprotection (Calon et al., 2004; Zhao et al., 
2011).
DHA is present at a high concentration in the phospholipids of the synaptic plasma 
membrane and synaptic vesicles (Marszalek & Lodish, 2005) particularly in the 
aminophospholipids (PE and PS) of the neuronal membranes where it regulates 
neuronal activity by modulating receptors, ion channels and signalling proteins (Garcia 
et al., 1998). It was reported that DHA has a role as a ligand for the retinoid X receptor 
(RXR) receptor in the brain. RXR is a nuclear receptor act as a RXR) receptor (de 
Urquiza et al., 2000). DHA is also a precursor of the lipoxygenase product, 
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neuroprotectin D1, which is involved in the resolution of neuroinflammation (Bazan et 
al., 2005).
8. DHA IN CELLULAR SIGNALLING TO PROMOTE CELL SURVIVAL
As constituents of membrane bound phospholipids in neuronal cells, DHA participates 
in cell signaling in response to various stimuli. Neuro-2A and PC-12 cells showed that 
the presence of DHA confers some protective effects against DNA fragmentation during 
the serum starvation (Kim. et al., 2000). It was also evident that caspase-3 activity was 
reduced in the presence of DHA (Kim. et al., 2001) which facilitates the protection of 
neurons from undergoing apoptosis. Multiple evidence from studies in experimental 
models and from post mortem brain tissue demonstrates that this neurodegeneration is a 
result of death of neuronal cell caused by apoptosis and membrane loss of PUFAs in 
cortical brain regions (Akbar & Kim, 2002; Culmsee & Landshamer, 2006; Florent et 
al., 2006; German et al., 2006; Kim. et al., 2000; Kishida et al., 1998; Wu et al., 2007;
Youdim et al., 2000). Apoptosis is also increased in patients with bipolar disorder, seen 
in proteome profiling (Herberth et al., 2011). Chronic stress leads to depression 
accompanied by neuronal apoptotic cell death as well (McKernan et al., 2009).
Phosphatidylinositol 3-kinase (PI3K)/Akt signaling is a critical pathway in cell survival
against apoptosis. DHA shown to promote neuronal cell survival by modulating Akt 
signaling pathway. Phosphatidylserine (PS), the major acidic phospholipid in cell 
membranes is increased through DHA facilitated membrane translocation or activation 
of Akt and promotes neuronal survival in Neuro 2A cells (Akbar et al., 2005).
Translocation (which is the essential step for the phosphorylation) and activation of Akt 
was examined to determine the target of the PS and PI (3)K/Akt pathway-dependent 
protection by DHA. The PH domain of Akt tagged with an enhanced green fluorescence 
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protein (EGFP-AktPH) was used to evaluate the interaction between the PH domain of 
Akt and the plasma membrane PIP3 generated by PI (3)K activation. After stimulation 
with IGF (insulin like growth factor), DHA enriched Neuro 2A cells showed 
considerably faster translocation in comparison with the non-supplemented control 
(Akbar et al., 2005).
DHA has major anti-inflammatory effect. Neuroinflammation is observed in diseases of 
the CNS including stroke, multiple sclerosis (MS), Alzheimer’s disease (AD) and 
Parkinson’s disease (PD), neurotrophic viral infections and in head traumas. These 
physiological events can promote the activation of the immune system in the CNS. The 
trigger in immune system exerts its effects in two ways. Firstly it can contribute to 
tissue damage, loss of neurons and dysfunction. Secondly it can on the other hand 
induce the neuroregeneration and tissue repair (Rivest, 2009). The immune system has a 
complex regulatory network formed by a huge range of mediators which coordinates the 
inflammatory responses (Medzhitov, 2008). Neuroinflammation and inflammatory 
mediator production are related to the pathophysiology of depression. Experimental
evidence showed that omega-3 fatty acids have antidepressant effects that in turn act 
against inflammation (Lu et al., 2010).
Overproduction of prostaglandins (PG) at inflammatory sites is directly related 
overexpression of cyclooxygenase (COX)-2. DHA can diminish the induction COX-2
WKURXJKWKHLQKLELWLRQRI1$'3+DQG3.&İ(Massaro et al., 2006).  They also have 
elaborated the activity of DHA in reducing the COX-2 promoter activity, activation of 
NF-ț%DQGQXFOHDUWUDQVORFDWLRQRISDQGSURGXFWLRQRILQWUDFHOOXODUUHDFWLYHR[\JHQ
species (ROS) all of which are indicative to induce cellular apoptosis (Massaro et al., 
2006). Taken all these consequences in consideration it is clear that DHA inhibits 
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neuronal apoptosis and promotes cell survival having the potential to alter the diseased 
state of the brain.
DHA has potential anti-inflammatory effects through the stimulation of G-protein 
coupled receptor 120 (GPR120). GPR120 protein functions as a receptor for omega-3
fatty acids and is encoded by the GPR120 gene. In the subsequent study RAW264.7 
cells (murine macrophage-like cell line) were pre-treated with DHA following treatment 
with LPS and TNF-Į5HVXOWVVKRZHGWKDW'+$VWURQJO\LQKLELWVWKHF\WRNLQHVHFUHWLRQ
and the level of inflammatory gene expression in RAW264.7 cells (Oh et al., 2010).
Resolvins and Protectins are newly discovered lipid mediators biosynthesized from the 
omega-3 fatty acids including DHA and EPA (Ariel & Serhan, 2007; Mehta et al., 
2009; Serhan, 2006; Xu et al., 2010) through the COX-2 pathway in the presence of 
aspirin (Serhan et al., 2004; Serhan et al., 2002). Resolvins and Protectins are named 
based on their specific duration and magnitude of inflammation in host models 
(Yacoubian & Serhan, 2007). Resolvins are produced from eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA) in the resolution phase following acute 
inflammation. However, Protectins are docosahexaenoic acid (DHA)-derived mediators
that are prominent with the presence of a conjugated triene double bond structure and 
22 carbons with 6 double bonds. Both lipid mediators possess anti-inflammatory 
characteristics (Serhan et al., 2008). Clinical trials confirmed the potential anti-
inflammatory and immune-regulatory activity of Resolvins and Protectins in the CNS 
(Mehta et al., 2009; Serhan et al., 2002), which indicate the anti-inflammatory activity 
of DHA. 
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The presence of high levels of proinflammatory cytokines, including interleukin-ȕ,/-
ȕ,/-6, and tumor necrosis factor-Į71)-ĮDVZHOODVLQWHUIHURQ-Ȗ,)1-ȖKDVEHHQ
detected in depressed patients (Maes et al., 2009). Behavioral studies conducted in 
animals and clinical trials illustrated that proinflammatory cytokines induced 
behavioral changes that symptoms similar to depression (Dantzer et al., 2008; Miller et 
al., 2009). Several studies demonstrated that DHA is able to inhibit the expression of 
inflammatory cytokines and monocyte adhesion to endothelial cells (De Caterina et al., 
2000). Adhesion molecules are involved in facilitating intercellular binding and 
communication. They play major roles in governing cell-to-cell interactions that are 
necessary for several physiological functions like cell growth and differentiation, 
inflammation, pathogen detection, embryonic development and wound repairs. 
Adhesion molecules have a crucial function in recruiting the neutrophils to the site of 
inflammation (Etzioni, 1996). Experiment with human venous endothelial cells have 
demonstrated that DHA significantly decreases cytokine-induced expression of 
endothelial leukocyte adhesion molecules, secretion of inflammatory mediators, and 
leukocyte adhesion to cultured endothelial cells (De Caterina et al., 1994). Beta amyloid 
$ȕ SHSWLGH LV FRQVLGHUHGDV WKHSDWKRORJLFDOKDOOPDUNRI$O]KHLPHU¶V GLVHDVH $'.
Pro-inflammatory cytokines are proved to be involved and interact with the processing
DQG SURGXFWLRQ RI $ȕ SHSWLGH (Blasko et al., 1999). Experiment in patients with AD 
subjected to DHA and EPA supplement have shown to reduce the release of 
inflammatory cytokines thus reduce the risk of inflammation (Serini et al., 2012).
9. TRANSPORT MECHANISM OF DHA INTO THE CELL MEMBRANE
The mechanisms of cellular DHA uptake are not well understood. The process of DHA
metabolization and diffusion in the blood circulation is still an area to be explored. 
Human study with radiolabeled [13C] DHA suggested that after hepatic secretion DHA 
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appears in plasma as non-esterified fatty acids (NEFA) (free DHA) in a time dependent 
manner (after 6 hours of ingestion). It was further declined after 6 hours. Esterified 
DHA (DHA conjugated with LPC) has a lower rate of appearance in plasma compared 
to free DHA. Appearance of DHA in the blood may involve different metabolic 
pathways (Lemaitre-Delaunay et al., 1999).
There are two hypotheses of fatty acid transport have been identified in the delivery of 
DHA from blood to the brain. First one is diffusion through the plasma membrane that 
is independent of a protein carrier. The second one is carrier-mediated uptake involving 
protein transporters (Mitchell. & Hatch, 2011). A diffusion mechanism of the FA 
transport has three distinct steps including adsorption of the FA onto the membrane, 
translocation and release of internalized FA (Hamilton et al., 2001). All these steps were 
confirmed using fluorescent labeled FA. The authors have observed the labeled FA 
absorb to the adipocyte plasma membrane and diffuse throughout the membrane 
through flip-flop mechanism. Trafficking of fatty acid within the brain cells is 
maintained by several membrane associated fatty acid binding/transport proteins such as 
fatty-acid-binding protein (FABP, 43 kDa), fatty acid translocase (FAT, 88 kDa), fatty 
acid transporter protein (FATP, 63 kDa) (Dutta-Roy, 2000) and caveolin-1 (Zlokovic, 
2008). Some or all these proteins are expressed during neuronal growth and 
development in the brain (Balendiran et al., 2000; Owada et al., 1996).
There are nine different subtypes of fatty-acid-binding protein (FABP) found in 
targeting specific tissues (Stremmel et al., 2001). According to their localization FABPs 
are divided into two different protein families, eg; Plasma membrane-associated 
(FABPpm) (Stremmel et al., 1985) and cytosolic (FABPc) (Ockner et al., 1972). Several 
studies demonstrated that over-expression or inhibition of FABPpm changes the mode of 
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uptake of cellular fatty acid either by enhancing or inhibiting the cellular uptake (Berk 
et al., 1990; Stremmel & Diede, 1989). Owada and associates in 2006 generated mice 
containing a null mutation in the FABP gene to study the role of FABP in FA uptake.
From the histological study they found that DHA content was decreased in the brain 
during the neonatal period (Owada et al., 2006) that implied the involvement of FABP 
in cellular uptake of FA. Figure 3 demonstrate a simplified pathway showing a 
suggestive route of DHA to be carried out from diet to the brain. 
10. OBSTACLES OF THE BLOOD BRAIN BARRIER (BBB)
The Blood-brain barrier (BBB) is a dynamic and complex interface between peripheral 
blood circulation and the central nervous system that actively regulates the influx and 
efflux at the blood-brain interface (Lichota et al., 2010; Obermeier et al., 2013). BBB
helps maintain the brain homeostasis by selectively delivering nutrients according to the 
neuronal needs by controlling the passage of molecules and ions and facilitate the 
protection of the CNS from toxins and pathogens (Abbott, 2002; Abbott & Romero, 
1996; Abbott et al., 2006; Begley & Brightman, 2003; Neuwelt et al., 2011; Obermeier 
et al., 2013; Risau & Wolburg, 1990; Zlokovic, 2008, 2011). One of the major 
obstructions in the development of therapeutics for the disorders of central CNS and its 
pre-clinical trials is to permeate through the BBB (Banks, 2016; Brasnjevic et al., 2009).
11. CROSSING THE BBB
There are several means of transport by which smaller and few of the larger molecules 
that are necessary for maintaining the brain homeostasis have passage through the BBB 
to reach neuronal target (Zlokovic, 2008). Some of these transport systems of BBB 
include carrier-mediated transport (CMT) system that facilitate transport of necessary 
polar metabolites and nutrients includes glucose, amino acids, amines, nucleosides and
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small peptides into the CNS (Banks, 2016; Begley & Brightman, 2003; Pardridge, 2005;
Zhao. & Zlokovic, 2014). Receptor-mediated transport (RMT) involved in transport of 
few proteins, macromolecules, and peptides by a process known as receptor-mediated 
transcytosis (Pardridge, 2012). Ion transporters are active ATP-dependent transporters 
associated with meeting high energy demands of BBB and maintaining correct fluid 
balance in the brain.(O'Donnell et al., 2006; Redzic, 2011; Vorbrodt, 1988). Passive 
transport by cerebrospinal fluid (CSF) is another means of transport that helps BBB to 
get rid of potentially toxic substances (Zlokovic, 2008). Peptide transporters (PTR) and 
receptors are responsible for the membrane transport of various peptides (Rubio-Aliaga 
& Daniel, 2008). Adsorptive-mediated transcytosis (AMT) is mediated by cationic 
macromolecules. Some polar solutes may have access through modulated tight junctions 
(TJs) involving aqueous paracellular pathway (Begley & Brightman, 2003).
12. TRANSPORT OF DHA INTO BRAIN ACROSS THE BBB
A recent report confirmed the importance of the major facilitator super family domain 
containing 2a (Mfsd2a) transporter in the BBB formation and maintaining its integrity 
and function (Ben-Zvi et al., 2014). It was also demonstrated the involvement of 
Mfsd2a as a transporter for the DHA across BBB into the endothelial cell of the brain 
(Nguyen et al., 2014). In vivo and in vitro experiments concluded Mfsd2a as the major 
transporter in BBB that mediates brain uptake of DHA that is essential for normal brain 
growth and cognitive function (Nguyen et al., 2014). A significant reduction of brain 
DHA level along with loss in neuronal cells and reduced brain size was reported 
(Nguyen et al., 2014). From In vivo experiments they have further demonstrated that 
Mfsd2a facilitate DHA transport only when DHA is attached to the lipid 
lysophosphatidylcholine (LPC) and brain’s uptake of DHA only involve Mfsd2a-
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dependent transport of LPC–DHA. LPC act as DHA’s carrier across the BBB providing
a good evidence on how essential fatty acids enter the brain.
Another intracellular carrier protein, fatty acid-binding protein 5 (FABP5) has recently 
been appeared as an important transporter for DHA to cross BBB. Pan et al
experimented FABP5 siRNA and 14C-DHA into C57BL/6 mice and immortalized 
human brain microvascular endothelial (hCMEC/D3) cells to assess if the uptake of 
DHA is dependent on FABP5. In situ transcardiac perfusion was applied in C57BL/6 
mice and found a reduced BBB influx rate of 14C-DHA in FABP5-deficient C57BL/6 
mice than in wild-type. Transfection FABP5 siRNA in hCMEC/D3 cell resulted in 
decreased FABP5 protein and mRNA expression that correlates reduced 14C-DHA 
cellular uptake. This study concludes the involvement of FABP5 to bind DHA and 
promote brain endothelial cell uptake and subsequent BBB transport of DHA and 
facilitating neuronal function (Pan et al., 2015)
13. ROLE OF DPA AND EPA IN THE BRAIN.
In addition to DHA, other omega-3 fatty acids such as docosapentaenoic acid (DPA) 
and eicosapentaenoic acid (EPA) have a profound effect in the brain function (Bauer et 
al., 2014; Dyall, 2015; Kelly et al., 2011; Vedin et al., 2008). There are very few 
literature available demonstrating the role of DPA in the brain (Byelashov et al., 2015;
Kaur et al., 2010; Kaur et al., 2011). It was demonstrated that short term dietary 
supplementation of DPA in Sprague–Dawley rats in their age 5 weeks could increase 
the concentration of DHA and EPA in liver significantly and deposited into adipose 
tissue (Kaur et al., 2010) that can signify the ability of DPA to retro convert DHA and 
EPA that in turn can contribute to the better cognitive health. Investigation from 
mammals have also revealed the neuroprotective characteristics by treating adult rats 
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injured from spinal cord compression. EPA treated rats showed decreased axonal 
injury with better neuronal survival in the site of injury (Lim et al., 2010).
Figure 3: Steps involved in the anticipated pathway of DHA incorporation from diet into the 
brain. Blue arrow represents the concentrated area and content of the thesis work.
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HYPOTHESIS
Based on the experimental observations, it was hypothesized that various forms of DHA 
such as free DHA, phospholipid DHA and nanoliposomal DHA will have different effect 
in protecting human neuronal cells from apoptosis induced by apoptotic inducing 
agents including staurosporine and hydrogen peroxide. It was expected that the least 
complex DHA eg: free DHA would have higher potential where phospholipid DHA may 
have the least potential in neuroprotection.
AIM OF THE STUDY AND PROJECT DESCRIPTION
General objective:
The overall aim of this study was to investigate the effect of free DHA, DHA-PLs and 
nanoliposomal DHA on reducing apoptotic cell death in human neuronal cells exposure
to apoptotic agents and to measure the incorporation of DHA phospholipids and 
nanoliposomes into cellular lipids to prevent neuronal cell death. 
Specific objectives:
The experimental procedures were undertaken to accomplish the following objectives:
¾ To measure the effects of free DHA, DHA-PLs, DPA and EPA and 
nanoliposomal DHA in the prevention of neuronal death in cells exposed to 
apoptotic agents through pre and co-treatment, by measuring cell viability assay, 
toxicity assay and western blot to determine pro-apoptotic protein BAX.
¾ To determine the incorporation of nanoliposomal DHA into cellular lipids in 
cultured human neuronal cells and cellular lipid profile analysis of NT2 cell in 
response to the treatment of nanoliposomal DHA by lipidomic study.
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¾ To characterize the electrophysiological response of DHA treated cortical 
neuron on microelectrode array to evaluate the improvement of signal flow 
between neurons.
THESIS OUTLINE
This thesis contains five chapters, including one introductory and four experimental 
chapters. Details of each chapter are as follows.
 Introductory chapter
¾ Chapter one includes a brief background of the study and literature reviews 
about the role of DHA in the prevention of neuronal cell death.
 Experimental chapters
¾ Chapter two is comprised of the results of the effect of free DHA (DHA-
FFA) and DHA containing phospholipids (DHA-PLs) in prevention of cell 
death induced by STS and H2O2 in a neuronal model NT2 cell. Two 
different treatment paradigms were used (co and pre-treatment) to 
investigate the preventive effects of DHA-FFA and DHA-PLs against cell 
death caused by apoptosis in NT2 cell.
¾ Chapter three describes the results from the study of the comparative role
of omega-3 fatty acids, including DHA, DPA and EPA in the prevention 
neuronal apoptosis. This study was conducted using the NT2 cell line using 
similar treatment paradigms.
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¾ Chapter four describes the effects of DHA nanoliposomes compared to free 
DHA on prevention of neuronal apoptosis to establish if different DHA 
formulations had differential effects. Two different nanoliposomes were 
tested (MFGM and soy) to establish if there was improved capacity in 
delivering DHA to the neuronal membrane resulting improved inhibition of 
apoptotic cell death in NT2 cells.
¾ Chapter five describes the steps and results of characterization of the effect 
of DHA on primary hippocampal cell activity that might be associated with
inhibition against neuronal apoptosis. An animal cell model (mouse cortical 
neuron) was tested using a microelectrode array technique to characterize the 
response of DHA treated cortical neurons.
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CHAPTER 2
 
Role of DHA-free fatty acid and DHA-
phospholipids in preventing neuronal 
apoptosis induced by STS and H2O2
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ABSTRACT
Docosahexaenoic acid (DHA) is one of the major omega-3 polyunsaturated fatty acids 
(PUFAs) in the mammalian brain. DHA has been shown to have protective effects 
against neuronal apoptosis. Effects of DHA treatment against neuronal apoptosis were 
investigated on neuronally-committed teratocarcinoma NT2 cells using different lipid 
forms of DHA; as the free fatty acid (FFA) and DHA incorporated phospholipids 
(DHA-PLs) including: PC-16:0-22:6, PE-18:0-22:6 and PE di-22:6 (10μg/ml of final 
concentration). The protocol used a prevention and a rescue paradigm of neuronal cells 
from cell death that involve co-treatment and pre induced by the exposure to two 
apoptotic agents, 10 nM of staurosporine (STS) and 300μM of hydrogen peroxide 
(H2O2). Cellular responses from treated cells showed DHA-FFA and DHA-PLs have a 
preventive effect against neuronal cell death in both paradigms. DHA-FFA was more 
efficient than DHA-PLs in neuroprotection that may relate to the differences in the 
incorporation of the DHA into the cells. Lipidomic study also revealed free DHA 
treatment increase several cellular phospholipid species namely 
Phosphatidylcholine:PC (576%), Lysophosphatidylcholine:LPC (715%), 
Phosphatidylethanolamine: PE (415%), Phosphatidylinositol: PI (392%) and 
Phosphatidylserine: PS (420%) was observed. These results could indicate the potential 
use of DHA in its free fatty acid form in promoting and maintaining a healthy brain. 
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1. INTRODUCTION
Docosahexaenoic acid (DHA) plays several roles in the neurochemical processes in the 
brain and modulates brain function (Horrocks & Farooqui, 2004; Kidd, 2007), brain 
structure, signaling and plasticity (Crupi et al., 2013; Salem et al., 2001; Sharma et al., 
2012). Neuronal apoptosis is a common feature of central nervous system of a great 
importance  because progressive loss of neuronal cells by apoptosis is believed to be 
one of the major causes of neurodegenerative disorders (Friedlander & Yuan, 1998;
Kanazawa, 2001; Kermer et al., 2004; Mattson, 2000; Okouchi et al., 2007). Several in-
vitro and in-vivo studies demonstrated the neuroprotective role of DHA against neuronal 
apoptosis by altering the composition of membrane phospholipid and modulating anti-
apoptotic mechanism in the neuronal cells (Akbar & Kim, 2002; Calderon & Kim, 
2007; Cao et al., 2005; Kim et al., 2001; Kim et al., 2000).
The aim of this chapter was to assess the role of free DHA (DHA-FFA) and DHA 
incorporated into three different phospholipids (PLs) including: PC-16:0-22:6, PE-18:0-
22:6 and PE di-22:6 in the prevention of neuronal cells from death induced by the 
exposure of two apoptotic agents: staurosporine (STS) and hydrogen peroxide (H2O2). 
The reason for choosing these particular PLs including phosphatidylcholine (PC), 
phosphatidylethanolamine (PE) is because of their abundance in brain cell membranes 
(Kakela et al., 2003; Kwee & Nakada, 1988) and being actively involved in cellular
signalling process (Piomelli et al., 2007) in neuronal disorders like Alzheimer’s disease 
(Bascoul-Colombo et al., 2016; Bennett et al., 2013) and traumatic brain injury as well 
(Abdullah et al., 2014). Animal study suggested that deficiency of n-3 PUFA may 
adversely affect the presence of DHA (22:6n-3) content in PC and PE of the brain PLs 
(Murthy et al., 2002).
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Limited findings have been reported on the effect of DHA-PLs on neuronal apoptosis. It
may help to reveal if DHA-PLs are effective in neuroprotection in addition to DHA-
FFA. STS has been used extensively to induce apoptosis in neurons (McCarthy et al., 
1997; Philpott et al., 1996; Wiesner & Dawson, 1996) and a variety of non-neuronal 
cells (Deshmukh & Johnson, 2000; Koh et al., 1995; Yang et al., 2014). The mechanism 
of apoptosis induction by STS may differ between cell types and concentration of STS as 
well (Deshmukh & Johnson, 2000). One of the main mechanisms of neuronal cells 
undergoing apoptosis is deprivation of nerve growth factor (NGF) after STS treatment 
(Deshmukh & Johnson, 1997). NGF deprived neuronal death is also involve expression 
of pro-apoptotic BCL-2 family protein, BAX as well as activation of caspase function
(Deckwerth et al., 1996). Use of H2O2 in inducing neuronal cell death in 
undifferentiated and differentiated neuronal cell lines (Datta et al., 2002; Zuliani et al., 
2005) was also described following the generation of reactive oxygen species (ROS) 
(Giorgio et al., 2007) (Chen et al., 2009) that causes cell damage leading to cell death
(Clement et al., 1998; Rodriguez et al., 1997; Singh et al., 2007).
Experimental evidences showed that DHA can inhibit corticosterone-induced neuronal 
apoptosis in Primary Cultures of Postnatal Day 1/2 rat cortex. Neuroprotective effects 
of DHA were measured by cell viability (MTT) assay, immunocytochemistry, fatty acid 
analysis, PCR, ELISA and TUNEL for detecting apoptosis. Experimental results 
indicated DHA treatment potentially inhibited the adverse effects of corticosterone-
induced neuronal apoptosis in the culture. (Pusceddu et al., 2016). One of the major 
sign of neurodegeneration in AD is the deposition of amyloid-ȕ (Aȕ) peptide in senile 
plaques (Yankner, 1996). $ȕLQGXFHVQHXURQDOGHDWKLQDVHULHVRIPROHFXODUSDWKZD\
Part of these pathways are activation of c-Jun N-terminal kinase (JNK) and activation 
of the c-Jun transcription factor. Transcription of death inducer Fas ligand is activated 
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by c-Jun transcription factor and induces a cascade caspase activation leading to cell 
death (Morishima et al., 2001). Experimental evidence suggested that DHA treatment 
can prevents soluble amyloid-ȕ ROLJRPHUV LQGXFHG QHXURQDO DSRSWRVLV by changing
neuronal membrane properties thus inhibits cell injury and death-signalling pathways 
that reduces neurodegeneration in AD patient (Florent et al., 2006).
In this chapter, two different treatment strategies were tested. The first was co-treatment 
(Figure 1) where human neuronal like model cells (NT2) were co-treated with DHA-
FFA, DHA-PLs and apoptosis inducing agents for 48 hours. This unique approach is 
applied to explore the instant preventive measures of DHA if applied in a diseased state 
of the cell. Second one is pre-treatment (Figure 2). In this approach, NT2 cells were 
supplemented with DHA-FFA and DHA-PLs first and subsequently exposed to the cell 
death-inducing agent for a further 48 hours. The outcomes of these processes signify the 
ability of DHA-FFA and DHA-PLs to prevent the cells from adverse effect of induced 
apoptotic cell death.
2. MATERIALS AND METHODS
2.1 Cell Culture
Neuronally committed teratocarcinoma NT2 cells (NTERA-2 cl.D1 [NT2/D1] 
ATCC® CRL-1973) are well-characterized human cell line that grow well in culture but 
can be differentiated into human neuron-like cells (hNT neurons) cells after treatment 
with retinoic acid (Pleasure & Lee, 1993; Pleasure et al., 1992). NT2 cells were used as 
a model cell line to study the effects of DHA and DHA-PLs. STS was purchased from 
Enzo Life Sciences, Inc. Farmingdale, NY-11735, USA. H2O2 was purchased from 
Ajax Finechem, Thermo FisheU 6FLHQWL¿F 6FRUHVE\ 9,&-3179, Australia. The cells 
were routinely maintained in 1:1 (v/v) mixture of DMEM high glucose (Life 
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Technologies) and nutrient mixture F-12 (Life Technologies) supplemented with 10% 
(vol/vol) foetal bovine serum (Gibco BRL, Grand Island, NY, USA), 1X uridine and
kept at 37°C in a tissue culture incubator with 5% CO2 and 98% relative humidity. The 
cells were seeded in T-75 tissue culture flasks and cultured maintained for their growth.
1X phosphate buffered saline (PBS) from Gibco was used for washing off the medium 
prior detachment of cells from cell culture flask. Cells were detached by incubating the 
flask with 0.05% Trypsin-EDTA (Gibco, Life Technologies, USA). Exponentially 
growing cells were used throughout the experiments.
2.2 Co-treatment and Pre-treatment paradigms:
In co-treatment paradigm, NT2 cell were grown overnight. Next day cell culture 
medium was replaced with co-mixture of ȝJPO '+$-FFA/DHA-PLS with 10nM 
STS/300μM of H2O2 for 48hours (Figure 1). Where in pre-treatment, NT2 cells were 
pre-treated with DHA-FFA (ȝJPO) and DHA-PLs (ȝJPO) including PC-16:0-22:6, 
PE-18:0-22:6 and PE di-22:6  for 48 hours followed by the individual exposure to 
10nM of STS and 300μM of H2O2 for 48 hours (Figure 2) to study the preventive effects 
of different forms of DHA supplementation. All the final solutions were dissolved and 
prepared with culture medium. The cellular responses were measured by a cell viability 
assay and later on were confirmed by western blot using the pro-apoptotic marker 
protein BAX antibody (Abcam, Cambridge, MA 02139-1517, USA)
Page | 54  
 
Figure 1: Schematic diagram of co-treatment procedure. Red circles represent cells growing in 
medium and white circle represents cells attached to the dish after washout medium before 
trypsinization.
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Figure 2: Schematic diagram of pre-treatment procedure. Red circles represent cells growing in 
medium and white circle represents cells attached to the dish after washout medium before 
trypsinization.
2.3 Cell viability count
Cell viability assay were carried out using trypan blue (TB) exclusion method. TB 
exclusion assay is the most common methods for measuring cell viability. TB is cell 
membrane impermeable that enters into cells with compromised membrane and binds to 
intracellular proteins giving the cells a blue colour. The trypan blue exclusion assay is 
used in the enumeration of live (unstained) and dead (blue) cells in a given population 
(Mascotti et al., 2000; Repetto et al., 2008). Cell viability of NT2 cells was assessed 
after 48 hours exposure to DHA, DHA-PLs and STS/H2O2. Cells were seeded in 12 
welled cell culture plate prior STS and H2O2 treatment and incubated in normal cell 
culture condition described in cell culture technique. Next day the cells were treated 
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with subsequent treatment (co/pre-treatment) and incubated for 48 hours. After 48 
hours cells were washed with PBS and trypsinized with 0.05% Trypsin EDTA. Cells 
were then harvested and resuspended in complete culture medium. Viable cell number 
was counted by Countess™ Automated Cell Counter (Invitrogen, Carlsbad, California, 
United States) using 1:1 ratio of cell suspension and tryphan blue. Only the observed 
live cells were taken into consideration and graphed using Graphpad Prism 6 software 
(GraphPad Software, Inc. La Jolla, CA 92037 USA).
2.4 Western blot analysis
NT2 cells were seeded in T-25 flasks and pre or co-treated with ȝJPODHA and 
DHA-PLs with subsequent exposure of STS and H2O2 as described in section 2.1. After 
harvesting, the cells were treated with 2% SDS cell lysis buffer (10-mM EDTA, 50-mM 
Tris-base, pH 8.0) and sonicated for 30 Sec. Protein concentrations were measured 
using the BCA protein assay kit (ThermoFisher, Australia). Briefly, 50-ȝJVDPSOHVRI
protein were loaded on 15% SDS-PAGE gels and run for protein separation, transferred 
to nitrocellulose PHPEUDQHVȝPMillipore) and blocked with 5% non-fat milk in 
TBST buffer (20-mM Tris–HCl, 120-mM NaCl, 0.1% Tween-20) for 1 hour. The 
membrane was then incubated overnight at 4o C with primary antibody ȕ-actin in a 
ratio of 1:5000 and BAX in a ratio of 1:1000). The mouse monoclonal ȕ-actin antibody 
were purchased from Sigma, rabbit polyclonal BAX antibody were purchased from 
ABcam. After three washes (5 min each) with TBST (TBS containing 0.1% Tween-20), 
the membranes were incubated with subsequent horseradish peroxidase-conjugated 
secondary antibody in a ratio of 1:2000 (Merck Millipore, Australia) for 1 hour at room 
temperature. After three washes (5 min each) with TBST, proteins were visualized using 
the enhanced chemiluminescence method (Immobilon Western, Millipore Corporation, 
Billerica, MA, 01821, USA) and membrane images were taken by Chemidoc MP 
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System (Bio-Rad, California, USA). The protein expression levels were normalized to 
the expression of housekeeping gene ȕ-actin and expressed in percentage relative to the 
H[SUHVVLRQRIȕ-actin (Sigma-Aldrich, USA).
2.5 Flow cytometry analysis
NT2 cells were seeded and cultivated in 12 well plates at 37 °C and 5% CO2 in 
complete DMEM media described in section 2.1. Pre and co-treatment of cells were 
performed as described in section 2.1. Following treatments, conditioned media from 
treated wells were collected in 10 mL FACS tubes. Cells adhered to the wells were 
harvested using 0.5 mL of trypsin EDTA solution (0.05%). Corresponding conditioned 
medium were then combined with harvested media and were pelleted by centrifugation 
at 1000 rpm for 5 min at 4°C. Supernatant were aspirated and cell pellets were 
UHVXVSHQGHG LQ  ȝ/ RI 3%6 FRQWDLQLQJ  ȝJP/ SURSLGLXP LRGLGH 3, 6LJPD-
Aldrich, USA). Each individual samples were analysed with a FACS Canto II flow 
cytometer (BD Biosciences) immediately. 10,000 events were measured to determine 
the percentage of dead cells (cells positive for PI staining, excitation 538 nm/emission 
617 nm). Acquired data were analysed by Flowing Software (Turku Bioimaging, 
University of Turku, Finland)
2.6 Lipidomic analysis
NT2 cells were treated with 10μg/ml DHA and DHA-PLs for 48 hours. Cells were 
collected by trypsinization and kept in -800 C. Lipid extraction of treated NT2 cell pellet 
was performed using modified method of Folch et al. 1957 (Folch et al., 1957). Briefly, 
an internal standard mixture, containing between 50-1000 pmol of 23 non-physiologic 
and stable isotope-labelled lipids, was added to the randomized and sonicated cellular 
extracts. NT2 cell were pre-treated with DHA-FFA, PC-16:0-22:6, PE-18:0-22:6 and 
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PE di-22:6 for 48 hrs. Cells were harvested following the procedure described in the 
section 2.1. The lipids from cell lines were extracted with chloroform:methanol (2:1, 20 
volumes), mixed and sonicated for 30 min to assist the liberation of lipids from the 
proteins and allowed to stand for 20 min. Samples were centrifuged (16000g, 10 min) 
and the supernatant transferred to a 96 well plate and dried under a stream of nitrogen at 
40 °C. Immediately before analysis, samples were reconstituted in water saturated 
butanol and sonicated for 10min followed by addition of methanol containing 10 mM 
ammonium formate. Samples were centrifuged (5000g, 10 min) and transferred to glass 
vials. Lipidomic analysis was performed by HPLC, electrospray ionization-tandem 
mass spectrometry by using an Agilent 1200 liquid-chromatography system combined 
with a Biosystems API 4000 Q/TRAP mass spectrometer with a turbo-ionspray source 
(350°C) (AB SCIEX) and Analyst 1.5 data system (AB SCIEX). Over 300 individual 
lipid species were analysed by multiple reaction monitoring experiments. Individual 
species in each lipid class were summed up for statistical evaluation.
2.7 Statistical analysis
Statistical significances between treatments were determined using one-way ANOVA 
(Tukeys method) with the GraphPad Prism software (Version 6.07) (GraphPad 
Software, Inc. La Jolla, CA 92037 USA). Unless otherwise stated, the graphs shown 
here represent the mean ± S.E.M. for three independent experiments of control and 
treatment groups and P<0.05 was considered as statistically significant.
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3. RESULTS 
3.1. Optimize concentration of STS and H2O2 to induce cell death in NT2 cell line:
NT2 cells were exposed to staurosporine (STS) and hydrogen peroxide (H2O2) to 
establish the concentrations that significantly reduced the number of viable cells without 
killing them in a time- and dose-dependent manner. Cell viability and cell death in NT2 
cells exposed to H2O2 FRQFHQWUDWLRQVUDQJLQJIURPȝ0-1mM and STS concentrations 
ranging from QP WR ȝ0ZHUHPHDVXUHG DW WLPHSRLQWV RI      DQG
hours (data not shown). Time periods from 6-24 hours had a little effect on inducing 
cell death whereas 96 hours of treatment had a lethal effect and killed almost all the 
cells (data not shown).  A time point of 48 hours was selected for both STS and H2O2
DQG D FRQFHQWUDWLRQ RI QP ZDV VHOHFWHG IRU 676 )LJXUH $ DQG  ȝ0 IRU
hydrogen peroxide (H2O2) (Figure 3B) as optimum incubation condition to induce cell 
death. There was a significant reduction of cell growth (p<0.001) observed in both STS 
and H2O2 treatment reaching almost 50% compared to the control. 
Figure 3: Optimization of the STS and H2O2 concentrations to induce cell death: 
Viability of NT2 cells when treated with (A) 10nm of STS and (B) ȝ0RIH2O2 for 48 
hours. Trypan blue exclusion method was used to measure the cell viability. Graphs represent 
the mean ± S.E.M. for three independent experiments of control and treatment groups. 
Superscripted letters show significant differences between the treatments (p<0.05).
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3.2. DHA and DHA-PLs improve cell viability and protect cell from STS and 
H2O2 induced cell death in co-treatment paradigm.
To measure the role of DHA in preventing neuronal cells death, cells were exposed to 
DHA-FFA and DHA-PLs in the presence of STS or H2O2 for 48 hours. Cells treated 
with STS were 50% viable compared to untreated control, where the cells treated with 
DHA-FFA were 85% viable (p<0.0001). Treatment with DHA-PLs namely PC-16:0-
22:6, PE-18:0-22:6 and PE di-22:6 also showed improved cell viability comparative to 
STS treatment. In PE di-22:6 treatment, higher cell viability was observed (p<0.001) 
(Figure 4A). PC-16:0-22:6 and PE-18:0-22:6 tend to be less effective in increasing cell 
variability compared to DHA-FFA against STS treatment. There were significant 
differences found between DHA-FFA and PC-16:0-22:6 (p<0.0001), DHA-FFA and 
PE-18:0-22:6 (p<0.05), DHA-FFA and di-DHA (p<0.001) treatment.
In H2O2 treatment, a similar activity trend as above was visible where cell viability was 
approximately 60% relative to control. DHA-FFA treated cells showed substantial 
increase in cell viability by approximately 90% compared to the control cells where. On 
the other hand, cell viability in the treatment of PC-16:0-22:6, PE-18:0-22:6 and PE di-
22:6 approximately 80%, 90% and 95% respectively compared to control (Figure 4B)
were observed. There was significant difference observed between DHA-FFA and PC-
16:0-22:6 (p<0.0001), DHA-FFA and PE di-22:6 (p<0.0001) treatments but there was 
no significant difference in increasing cell viability found between DHA-FFA and PE-
18:0-22:6 treatment. In both STS and H2O2 co-treatment, PE di-22:6 showed higher 
efficiency in increasing cell viability than any other DHA-PLs and DHA-FFA. PC-
16:0-22:6 treatment was least significant compared to all treatments (Figure 4B).
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Figure 4: Co-treatment of cells with DHA and DHA-PLs improves cell viability
Cell viability assay of NT2 cells showing the effect of DHA-FFA and DHA-PLs co-treated with 
(A) STS and (B) H2O2 respectively for 48 hours. Trypan blue exclusion method was used to 
measure the cell viability. Graphs represent the mean ± S.E.M. for three independent 
experiments of control and treatment groups. Superscripted letters show significant differences 
between the treatments (p<0.05).
3.3. DHA and DHA-PLs pre-treatment improves NT2 cell viability
In pre-treatment paradigm, highest cell viability approximately 80% was observed in
DHA pre-treatment (p<0.0001) than that of STS treated cells where the viability was
approximately 50% compared to control (Figure 5A). PE di-22:6 treatment shown to be 
less effective in increasing cell viability approximately 60% to that of control
(p<0.0001). Cell viability were recorded in both PC-16:0-22:6 and PE-18:0-22:6 pre-
treatment were approximately 70% compared to control (p<0.0001) (Figure 5A). There 
were significant differences observed between DHA-FFA and PC-16:0-22:6 (p<0.01), 
DHA-FFA and PE-18:0-22:6 (p<0.01), DHA-FFA and PE di-22:6 (p<0.0001)
treatments in increasing cell viability against STS treatment.
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In pre-treatment following H2O2 exposure, a significant increase in the cell viability of 
approximately 85% was observed by DHA-FFA enrichment where it was 
approximately 55% in H2O2 treatment (p<0.0001) compared to control. PC-16:0-22:6 
and PE-18:0-22:6 treatment was less effective than DHA-FFA and contributed to a
higher cell viability by almost 50-55% compared to H2O2. PE di-22:6 had the similar 
effect to DHA in increasing cell resistance to apoptosis induced by H2O2. There was a
significant difference found only between DHA-FFA and PC-16:0-22:6 (p<0.05) 
(Figure 5B).
An almost similar viability pattern was observed in both STS and H2O2 treatment 
paradigms apart from the treatment of PE di-22:6. Cells treated with PC-16:0-22:6 and 
PE-18:0-22:6 were less effective compared to DHA-FFA in increasing the cell viability 
against STS and H2O2 induced cell death. 
Figure 5: Pre-treatment of cells with DHA and DHA-PLs improves cell viability
Cell viability assay showing the effects of pre-treatment with DHA and DHA-PLs compared to 
control cells for 48 hours followed by the treatment with (A) STS and (B) H2O2 for further 48 
hours. Trypan blue exclusion method was used to measure the cell viability. Graphs represent 
the mean ± S.E.M. for three independent experiments of control and treatment groups. 
Superscripted letters show significant differences between the treatments (p<0.05).
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3.4. DHA and DHA-PLs treatment protected NT2 cells from cytotoxic effects of
STS and H2O2
Propidium iodide (PI) was used in Flow cytometry to assess the cytotoxic effects of 
H2O2 and STS in both co and pre-treatment paradigm where PI stained dead cells 
indicated in red. In co-STS, cells treated with STS showed 9% of dead cells where 
DHA-FFA and DHA-PLs treatment were shown with approximately 2-3% dead cells, 
which was almost to the count of control level. (Figure 6C). Cells co-treated with H2O2
contained 22% dead cells. DHA-FFA, PC-16:0-22:6, PE-18:0-22:6 and PE-18:0-22:6 
treatments were shown to have 8-13% dead cells which was close control level (Figure 
7C). 
Cells pre-treated with DHA-FFA and DHA-PLs before exposure to STS had less dead 
cells compared to cells that were treated with STS alone that contained approximately
14% dead cells. DHA-FFA, PC-16:0-22:6, PE-18:0-22:6 and PE di-22:6 pre-treatment 
reduced the cell death to the level of 5%, 8%, 10% and 11% respectively (Figure 8C). 
On the other hand, cells treated with H2O2 showed 35% cell death compared to control 
that had shown 17% dead cells. DHA-FFA treatment reduced cell death to 25%. But in 
cells pre-treated with PC-16:0-22:6, PE-18:0-22:6 and PE di-22:6 the amount of cell 
death ranged from approximately 30% to 39% (Figure 9C).
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Figure 6: DHA-FFA and DHA-PLs reduced cell death caused by STS co-treatment
Flow cytometry analysis with propidium iodide showing % of dead cells of NT2 when DHA-
FFA and DHA-PLs were co-treated with STS compared to untreated cells (control). (A) Dot 
plots represent % of PI stained dead cells (red) and live cells (black) in each treatments (B)
Overlay histogram represents accumulated live and dead cell count in each treatments with 
colour coded lines. (C) Bar graph represents dead cell count (PI stained cells in %) for 
subsequent treatments. Graphs represent the mean ± S.E.M. for three independent experiments 
of control and treatment groups. Superscripted letters show significant differences between the 
treatments (p<0.05).
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Figure 7: DHA-FFA and DHA-PLs reduced cell death caused by H2O2 co-treatment
Flow cytometry analysis with propidium iodide showing % dead cells of NT2 when DHA and 
DHA-PLs were co-treated with H2O2 compared to untreated cells (control). (A) Dot plots 
represent % of PI stained dead cells (red) and live cells (black) in each treatments (B) Overlay 
histogram represents accumulated live and dead cell count in each treatments with colour coded 
lines. (C) Bar graph represents dead cell count (PI stained cells in %) for subsequent treatments.
Graphs represent the mean ± S.E.M. for three independent experiments of control and treatment 
groups. Superscripted letters show significant differences between the treatments (p<0.05).
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Figure 8: DHA-FFA and DHA-PLs reduced cell death caused by STS in pre-treatment 
Flow cytometry analysis with propidium iodide showing % dead cells of NT2 when pre-treated 
with DHA and DHA-PLs followed by STS treatment compared to untreated cells (control). (A)
Dot plots represent % of PI stained dead cells (red) and live cells (black) in each treatments (B)
Overlay histogram represents accumulated live and dead cell count in each treatments with 
colour coded lines. (C) Bar graph represents dead cell count (PI stained cells in %) for 
subsequent treatments. Graphs represent the mean ± S.E.M. for three independent experiments 
of control and treatment groups. Superscripted letters show significant differences between the 
treatments (p<0.05).
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Figure 9: DHA-FFA and DHA-PLs reduced cell death caused by H2O2 in pre-treatment
Flow cytometry analysis with propidium iodide showing reduction in dead cells of NT2 when 
pre-treated with DHA and DHA-PLs followed by H2O2 treatment. (A) Dot plots represent % of 
PI stained dead cells (red) and live cells (black) in each treatments (B) Overlay histogram 
represents accumulated live and dead cell count in each treatments with colour coded lines. (C)
Bar graph represents dead cell count (PI stained cells in %) for subsequent treatments. Graphs 
represent the mean ± S.E.M. for three independent experiments of control and treatment groups. 
Superscripted letters show significant differences between the treatments (p<0.05).
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3.5. DHA and DHA-PLs treatment reduced the expression of pro-apoptotic BAX 
protein
Western blot analyses were carried out to detect the expression level of the pro-
apoptotic marker protein BAX. The expression of BAX was normalised to the 
expression level of housekeeping gene, ȕ-actin. In STS treatment, expression of BAX 
was approximately 180% compared to control value of 100% (p<0.0001) (Figure 10A). 
BAX was decreased to approximately 140% and 115% in DHA-FFA, PE di-22:6
treatment respectively. The BAX expression levels in PC-16:0-22:6 and PE-18:0-22:6 
treatment was approximately 160% (Figure 10A). In case of H2O2 co-treatment, BAX 
level was approximately 127% relatively higher to the control level (100%). The only 
significant reduction of BAX was observed in DHA treatment (p<0.05) where BAX was 
lowered to approximately 95% that is closer to control level. There were no significant 
effects of PC-16:0-22:6, PE-18:0-22:6 and PE di-22:6 treatment in reducing BAX 
expression (Figure 10B).
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Figure 10: Effect of DHA and DHA-PLs on STS and H2O2 induced BAX expression in 
NT2 cells
Results of western blot showing the expression of pro-apoptotic marker BAX when NT2 cells 
were co-treated with free DHA and DHA-PLs and (A) Staurosporine, (B) H2O2. Graphs 
represent the mean ± S.E.M. for three independent experiments of control and treatment groups. 
Superscripted letters show significant differences between the treatments (p<0.05).
In the STS pre-treatment group, the expression of BAX was increased to aprox. 125%
compared to control level of (100%) by STS treatment. Apart from the treatment of PC-
16:0-22:6, DHA-FFA and other DHA-PLs treatment reduced the BAX expression level 
almost to the control level (Figure 11A). Similarly, in H2O2 pre-treatment group, an 
increased BAX expression was detected in H2O2 treatment to approximately125%. In 
addition, all DHA-FFA and DHA-PLs were found equally significant in reducing the 
BAX expression to that of control level (Figure 11B).
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Figure 11: Effect of DHA and DHA-PLs pre-treatment on STS and H2O2 induced BAX 
expression in NT2 cells:
Western blot results showing the expression of pro-apoptotic marker BAX when NT2 cells are 
pre-treated with free DHA and DHA-PLs followed treatment with (A) staurosporine and (B) 
H2O2. Graphs represent the mean ± S.E.M. for three independent experiments of control and 
treatment groups. Graphs represent the mean ± S.E.M. for three independent experiments of 
control and treatment groups. Superscripted letters show significant differences between the 
treatments (p<0.05).
 
3.5. Influence of DHA and DHA-PLs treatment in alteration in the abundance of 
DHA containing lipids in NT2 cells:
A semi-quantitative analysis of the lipid profile of NT2 cells following DHA-FFA and 
DHA-PLs treatment was carried out using liquid chromatography (LC)-mass 
spectrometry. All the % changes presented were in approximate quantity. In DHA-FFA
supplemented cells, an increase in the level of specific lipids was observed. Higher 
levels detected to that of untreated cells were PC (576%), LPC (715%), PE (415%), PI 
(392%) and PS (420%). Supplementation of DHA-FFA caused greater changes in levels 
of lipid species than DHA-PLs. Two major changes in LPC and PS were observed in 
both PC-16:0-22:6 and PE-18:0-22:6 treatment. In PC-16:0-22:6 treatment, LPC and PS 
increased to approximately 216% and 198% respectively where in PE-18:0-22:6 
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treatment the changes corresponded to 258% and 235%. However in PE di-22:6 
treatment there were increased levels of LPC (297%) and PS (277%). A noticeable
increased in the PE content was also observed in the treatment of PE di-22:6 (264%) 
which was higher compared to that of in PC-16:0-22:6 (160%) and PE-18:0-22:6 
(200%) treatments (Figure 12). 
Figure: 12: Temporal changes of NT2 cell’s lipid classes in response to DHA-FFA and 
DHA-PLs treatment. All lipid species were pooled together and presented in major lipid 
classes. Data presented as changes in percentage relative to control (100%).
4. DISCUSSION
A unique component of this study was the testing of DHA-PLs to elucidate their 
efficacy in the inhibition of neuronal cell death. Previous studies measuring the effect of 
DHA on neuronal cells have focussed on the pre-treatment of cells with DHA prior to 
exposure to apoptosis-inducing agents. In this study, two different treatment paradigms 
(co- and pre-treatment) of DHA and DHA-PLs were tested for prevention of STS and 
H2O2 induced cell death. The pre-treatment approach models preventive measures that 
could be applied to particular diseases. The co-treatment method was used as a
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comparative approach to the conventional pre-treatment approach. Both of the strategies 
showed significant preventive and protective effects of DHA and DHA-PLs from 
undergoing induced cell death.
In this study, it was found that a combination of 10 nM of STS with 48 hours of 
incubation was the most effective treatment to induce cell death to the NT2 cells. This
was relatively similar to the concentration of STS used in another study (Koh et al., 
1995). Other concentrations tested here ranging from 1nM-100nM and time points
ranging from 0 to 96 hours proved to be either too short to cause the effect or fatal to the 
cell in terms of inducing cell death. In relatively higher concentration and longer time 
form above stated ranges, more than 95% dead cells were visible (data not shown). 
In co-treatment apart from PE di-22:6, DHA-FFA was generally much more efficient in 
inhibiting cells from undergoing STS and H2O2 mediated cell death than other DHA-
PLs treatments. PE di-22:6 however showed higher viability of cells treated with DHA-
FFA in both STS and H2O2 treatments. Possible reasons could be that the presence of 
double DHA in PE di-22:6 may provide increased amounts of DHA to cells which in 
turn facilitate more membrane accumulation of DHA to provide protective effect. PE-
18:0-22:6 showed a higher protective effect to the cells than that of PC-16:0-22:6. This 
is consistent with the view that PE may play an important role in neurite outgrowth 
which play a major role in cellular signalling process that may enhance the cell survival 
and viability (Cao et al., 2005) which was similarly found in this study. It was also 
observed that the inhibitory effect of all forms of DHA treatments were higher in co-
treatment than in the pre-treatment paradigm. Possible reason for that might be the 
presence of extracellular DHA in the incubation medium in co-treatment that can 
provide the cell with more protection against apoptotic agents.
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The results from the pre-treatment of DHA and DHA-PLs following STS treatment with 
PE di-22:6 showed that this PL had less effect in maintaining cell viability than that of 
DHA-FFA and other DHA-PLs. The reason for that could be excess DHA accumulated 
from di-DHA in cell membrane, which might be neurotoxic to cultured cells (Cao et al., 
2005). In this study, DHA-FFA was more effective than DHA-PLs in preventing cells 
from undergoing cell death. Previous observations showed that DHA pre-treatment 
prevented the cells from STS induced apoptosis by promoting phosphatidylserine (PS) 
accumulation in cell membrane enabling them to resist cell death by promoting 
PI3K/AKT pathway which in turns reduce the pro-apoptotic caspase-3 activity (Akbar 
& Kim, 2002; Cao et al., 2005). Pre-treatment following H2O2 incubation produced
almost similar trend to that of co-H2O2 treatment. Differences in efficiency of DHA in 
preventing cells from STS and H2O2 induced cell death were probably due to the 
involvement of different anti-apoptotic pathways in STS and H2O2 (Akbar et al., 2005;
Singh et al., 2007). Several in vitro and in vivo molecular studies targeting molecular 
markers in anti-apoptotic pathways should be carried out to elucidate the exact anti-
apoptotic mechanism of DHA against STS and H2O2 induced apoptosis.
PI is a dye that is unable to penetrate through membrane and is excluded from viable 
cells leaving only dead cells stained. In several researches, PI was used to evaluate that 
cytotoxic effects of apoptotic agents occurred through DNA fragmentation (Jiang et al., 
2016; Riccardi & Nicoletti, 2006). Significant reduction in cell death by DHA and 
DHA-PLs in both co and pre-treatment data sets measured through flow cytometry (PI 
staining) indicates a strong anti-apoptotic property of DHA against apoptotic cell death.
It is well studied that the signal pathways leading to apoptosis or cell survival are 
regulated via pro- and anti-apoptotic signals that varies according to the type of cells 
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(Cory & Adams, 2002; Reed, 2002; von Harsdorf et al., 1999) which is in agreement 
with the current finding. The observed inhibition of STS induced cell death by DHA 
and DHA-PLs treatment in this experiment may involve in inhibiting or down 
regulating caspase-3 activation through AKT pathway as shown in previous 
experiments (Akbar & Kim, 2002; Kim et al., 2001)
Anti-apoptotic B cell lymphoma 2 (BCL-2) and pro-apoptotic BCL-2-associated X 
protein (BAX) are the major apoptosis regulatory proteins (Adams & Cory, 1998;
Alavian et al., 2011; Chipuk et al., 2012; Gross et al., 1999; Tait & Green, 2010). BAX 
protein expression in this study shows that in co-treatment, DHA reduced the BAX
induced by STS and H2O2. PC-16:0-22:6 and PE-18:0-22:6 treatments also had some 
effect in reducing BAX but were not as effective as free DHA and PE di-22:6. The
results support the findings of cell viability data in the same treatment sets and signify
the efficiency of DHA and DHA-PLs against apoptotic cell death.
Studies in neuronal cells demonstrate that DHA is highly concentrated in 
aminophospholipids, PE and PS in neuronal cells (Kim, 2008). It was estimated that 
DHA comprises 35-40% of total fatty acid in synaptic membrane PS from a 
compositional study of synaptic membrane phosphatidylserine (PS) (Hitzemann, 1981).
PS content in neuronal membranes can be changed according to the presence of 
membrane DHA despite of the strict regulation of cellular phospholipids levels (Kim et 
al., 2010). Several experimental evidence suggested that DHA supplementation can 
significantly increase the PS level in cultured neuronal cells (Akbar et al., 2005; Akbar 
& Kim, 2002; Guo et al., 2007; Kim et al., 2003; Kim et al., 2000). This statement is in 
agreement with the current results (Figure 12) showing DHA treatment did increase the 
PS content more than any other DHA-PLs supplementation. DHA supplementation also 
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increased the level of other membrane lipids such as LPC, PC, PE and PI by at least two 
fold compared to other DHA-PLs treatments. It is possible that DHA-FFA is 
incorporated into lipid membranes more rapidly than PL forms of DHA. This may be 
due to faster diffusion of free DHA through cell membrane where other forms take 
longer time and may utilise carrier-mediated mechanisms. This would explain why 
DHA-FFA is more effective in inhibition neuronal cell death compared to DHA-PL.
5. CONCLUSION
A comparative difference between DHA-FFA and DHA-PLs in inhibiting neuronal cell 
death was shown in two different treatment paradigms in this study. In both paradigms,
DHA-FFA found to be more effective than DHA-PLs in reducing STS and H2O2
induced cell death.  The co-treatment is a new and novel approach, which also 
demonstrated the ability to prevent neuronal cell death by the treatment of DHA-FFA
against induced apoptosis.
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CHAPTER 3
 
Comparative effects of different
omega-3 fatty acids in prevention of 
induced neuronal apoptosis
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ABSTRACT
Growing evidences suggests independent and shared neuroprotective effects of omega-3
fatty acids such as docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA) 
along with docosahexaenoic acid (DHA). A comparative independent neuroprotective 
efficiency of 10μg/ml DHA, DPA and EPA treatment was studied in an induced 
apoptotic culture system by the exposure to two apoptotic agents, 10 nM of 
staurosporine (STS) and 300 μM of hydrogen peroxide (H2O2) in a prevention and a 
rescue paradigm. Results of cellular response from both paradigm showed DHA, DPA 
and EPA have anti-apoptotic properties against induced apoptosis in the cell culture 
system. Among them DHA treatment has unique and imperative roles in protecting 
neuronal cells and reducing cell death up to control level from undergoing apoptosis. 
These results would suggest a greater understanding of the individual roles of DHA, 
DPA and EPA in the function of brain health.
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1. INTRODUCTION 
The human brain is highly enriched with fatty acids which includes polyunsaturated 
fatty acids (PUFAs) (Bazinet & Laye, 2014). Fatty acids that possess more than two 
carbon–carbon double bonds are defined as polyunsaturated fatty acids (PUFAs). 
PUFAs that contain 18 or more carbon atoms are often referred to as long-chain PUFAs 
(Mehta et al., 2009). The term n is also often used instead of the Greek Ȧ (omega) 
refers to the position of the last carbon–carbon double bond closest to the terminal 
methyl end (Fotuhi et al., 2009; Lauritzen et al., 2001). Fatty acids content of cell 
membrane vary between cells. The main unsaturated fatty acids in mammalian cells are 
linolenic acid (LA), arachidonic acid (AA), eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA). Neuronal cell membranes are unique between 
mammalian species in having arachidonic acid and DHA as their major unsaturated 
fatty acid (Crawford et al., 2009). Among them DHA is a predominant polyunsaturated 
fatty and is essential for normal neuronal development and function (Horrocks & 
Farooqui, 2004; Kawakita et al., 2006). Several biosynthetic reaction of desaturase and 
elongase are involved in synthesis of EPA, DPA and DHA (Parker et al., 2006).
'H¿FLHQF\ RI PUFAs contribute to several diseases discussed in previous chapter
(Connor et al., 1990; Marik & Varon, 2009). Apoptosis of neuron is involved in several 
neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson’s disease
(PD). Studies on polyunsaturated fatty acids (PUFAs) including DHA (22:6n-3), 
DPA(22:5n-3) and EPA (20:5n-3) have already demonstrated their protective effects
against the neuronal apoptosis (Akbar & Kim, 2002; Fotuhi et al., 2009; King et al., 
2006) which represent a potential treatment for a variety of neurodegenerative and 
neurological disorders (Simon C Dyall, 2015; S. C. Dyall & Michael-Titus, 2008; Kim. 
et al., 2001). Some recent human and animal studies also indicated neuroprotective 
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properties of n-3 PUFA in aging (Cutuli et al., 2014) and also have higher anti-
proliferative effect in cancerous cells (Morin et al., 2013).
There are several experimental evidences which demonstrated inhibitory effect of DHA 
against neuronal apoptosis (Akbar & Kim, 2002; Kim. et al., 2001; Kim. et al., 2000).
Details were described in the previous chapter explaining the effect of DHA and DHA-
PLs in neuroprotection. However, it is still elusive which particular PUFA has the most 
potent inhibitory effect against neuronal apoptosis. There is not enough experimental 
evidence showing comparative neuroprotective effects of n-3 PUFAs in-vitro. In the 
previous chapter, it was shown that DHA was effective in preventing neuronal apoptosis 
and protects cells from undergoing cell death induced by STS and H2O2. The aim of 
this study was to measure the comparative inhibitory effects of several n-3 PUFAs 
(including DHA, DPA and EPA) in the improvement of neuronal cell (NT2) function in 
apoptotic condition induced by STS and H2O2. This is a complementary work of the
previous study where the neuroprotective effect of DHA and DHA-PLs against induced 
cell death was shown. Identical death inducing agents, culture and treatment conditions 
were used as presented in previous chapter 2. This study was conducted to find the most 
potent PUFA that could potentially be beneficial as novel treatment against neuronal 
apoptosis.
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2. MATERIALS AND METHODS
2.1 Cell culture
Neuronally committed teratocarcinoma NT2 cells (NTERA-2 cl.D1 [NT2/D1] 
ATCC® CRL-1973) are well-characterized human cell line that grow well in culture but 
can be differentiated into human neuron-like cells (hNT neurons) cells after treatment 
with retinoic acid (Pleasure & Lee, 1993; Pleasure et al., 1992).  NT2 cells were used as 
a model cell line to study the effects of DHA-FFA, DPA and EPA. STS was purchased 
from Enzo Life Sciences, Inc. Farmingdale, NY-11735, USA. H2O2 was purchased 
IURP $MD[ )LQHFKHP 7KHUPR )LVKHU 6FLHQWL¿F 6FRUHVE\ 9,&-3179, Australia. The 
cells were routinely maintained in 1:1 (v/v) mixture of DMEM high glucose (Life 
Technologies) and nutrient mixture F-12 (Life Technologies) supplemented with 10% 
(vol/vol) foetal bovine serum (Gibco BRL, Grand Island, NY, USA), 1X uridine and 
kept at 37°C in a tissue culture incubator with 5% CO2 and 98% relative humidity. The 
cells were seeded in T-75 tissue culture flasks and cultured maintained for their growth. 
1X phosphate buffered saline (PBS) from Gibco was used for washing off the medium 
prior detachment of cells from cell culture flask. Cells were detached by incubating the 
flask with 0.05% Trypsin-EDTA (Gibco, Life Technologies, USA). Exponentially 
growing cells were used throughout the experiments.
NT2 cells were pre-treated with free ȝJPO DHA, DPA and EPA for 48 hours 
followed by the individual exposure to 10nM of STS and 300μM of H2O2 for 48 hours 
to study their preventive effects. To assess the role of fatty acids in the cell rescue, 
DHA, DPA and EPA were co-treated with 10nM of STS and 300μM of H2O2
individually for 48hours. The cellular responses were measured by a cell viability assay,
toxicity assay and later on were confirmed by Western blot using the pro-apoptotic 
marker BAX.
Page | 88  
 
2.2 Cell viability count
The Tryphan blue exclusion method was used to assess the cell viability after 48 hours 
of exposure to fatty acids and apoptosis inducing agents. Cells were seeded in 12 well 
cell culture plate and incubated in normal cell culture condition described in section 2.1.
Next day the cells were treated with subsequent fatty acid treatment and after the 
eventual time point of 48 hours, cells were washed with PBS and trypsinized with 
0.05% Trypsin EDTA. Cells were then harvested and resuspended in complete culture 
medium. Viable cell number was counted by Countess™ Automated Cell Counter 
(Invitrogen, Carlsbad, California, United States) using 1:1 ratio of cell suspension and 
tryphan blue. Only the observed live cells were taken into consideration and graphed 
using Graphpad Prism 6 software (GraphPad Software, Inc. La Jolla, CA 92037 USA).
2.3 Western blot analysis
NT2 cells were seeded in T-25 flaVNV DQG WUHDWHG ZLWK ȝJPO RI FA acids with 
subsequent exposure to 10nM of STS and 300 μm of H2O2 for 48 hours. At the 
conclusion of treatment, cells were collected through appropriate cell culture techniques 
and the pelleted cells were store at -80O C until further use. Pelleted cells were treated 
with 2% SDS cell lysis buffer (10-mM EDTA, 50-mM Tris-base, pH 8.0) and sonicated 
for 30 Sec. Protein concentrations were measured using the BCA protein assay kit 
(ThermoFisher, Australia). Briefly, 50-ȝJVDPSOHVRISURWHLQZHUHORDGHGRQ6'6-
PAGE gels and run for protein separation, transferred to nitrocellulose membranes 
ȝPMerckMillipore, New Zealand) and blocked with 5% non-fat (skimmed) milk 
in TBST buffer (20-mM Tris–HCl, 120-mM NaCl, 0.1% Tween-20) for 1 hour. The 
membrane was then incubated overnight at 4o &ZLWK SULPDU\ DQWLERG\ ȕ-actin in a 
ratio of 1:5000 and BAX in a ratio of 1:10007KHPRXVHPRQRFORQDOȕ-actin antibody 
were purchased from Sigma, rabbit polyclonal BAX antibody were purchased from 
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ABcam. After three washes (5 min each) with TBST (TBS containing 0.1% Tween-20), 
the membranes were incubated with subsequent horseradish peroxidase-conjugated 
secondary antibody in a ratio of 1:2000 (Merck Millipore, Australia) for 1 hour at room 
temperature. After three washes (5 min each) with TBST, proteins were visualized using 
the enhanced chemiluminescence method (Immobilon Western, Millipore Corporation, 
Billerica, MA, 01821, USA) and images of the membrane were taken by Chemidoc MP 
System (Bio-Rad, California, USA). The protein expression levels were normalized to 
WKHH[SUHVVLRQRIKRXVHNHHSLQJJHQHȕ-actin and expressed in percentage relative to the 
H[SUHVVLRQRIȕ-actin (Sigma-Aldrich, USA).
2.4 Flow cytometry analysis:
NT2 cells were seeded and cultivated in 12 well plates at 37 °C and 5% CO2 in 
complete DMEM media described in section 2.1. Pre and co-treatment of the cells with 
FA were performed as described in section 2.1. Following treatments, conditioned 
media from treated wells were collected in 10 mL FACS tubes. Cells adhered to the 
wells were harvested using 0.5 mL of trypsin EDTA solution (0.05%). Corresponding 
conditioned medium were then combined with harvested media and were pelleted by 
centrifugation at 1000 rpm for 5 min at 4°C. Supernatant were aspirated and cell 
SHOOHWVZHUHUHVXVSHQGHGLQȝ/RI3%6FRQWDLQLQJȝJP/SURSLGLXPLRGLGH3,
(Sigma- Aldrich, USA). Each individual samples were analysed with a FACS Canto II 
flow cytometer (BD Biosciences) immediately. 10,000 events were measured to 
determine the percentage of dead cells (cells positive for PI staining, excitation 538 
nm/emission 617 nm). Acquired data were analysed by Flowing Software (Turku 
Bioimaging, University of Turku, Finland)
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2.5 Statistical analysis
Statistical significances between treatments were determined using one-way ANOVA 
(Tukeys method) with the GraphPad Prism software (Version 6.07) (GraphPad
Software, Inc. La Jolla, CA 92037 USA). Unless otherwise stated, the graphs shown 
here represent the mean ± S.E.M. for three independent experiments of control and 
treatment groups and P<0.05 was considered as statistically significant.
3. RESULTS 
Optimal concentration and exposure time of STS and H2O2 to induce cell death in NT2 
cells were determined in the previous study (chapter 2). The 48 hours of exposure was 
selected as the optimum time for both STS and H2O2 treatments. Optimum 
concentration of 10n0 IRU 676 DQG  ȝ0 IRU +2O2 was selected as the final 
concentration to induce cell death without killing the cells completely. 
3.1. Omega-3 fatty acids increase cell viability from STS and H2O2 induced cell
death in co-treatment paradigm.
The effects of omega-3 fatty acids on cell viability were assessed after 48 hours of co-
treatment with STS and H2O2 respectively. NT2 cells were exposed to DHA, DPA and 
EPA in the presence of STS and H2O2 for 48 hours. In co-STS paradigm, results 
indicated approximately 60% reduction in cell viability compared to control when 
treated with STS. A significant increase in viability was detected with all three omega-3
fatty acid treatments (Figure 1 A). Cells with DHA co-treatment had an increased 
viability to approximately 80% where in DPA and EPA treatments, it was
approximately 75% and 70% compared to control. There were no significant differences
in treatment effects between DHA and DPA and between DPA and EPA. But the 
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difference between DHA and EPA treatment was significant where cells treated with 
DHA had a higher viability compared with DPA and EPA (p<0.05) (Figure 1 A).
Figure 1: Treatment of cells with omega-3 FAs improve cell viability against STS and 
H2O2 in co-treatment
Cell viability assay showing the effect of omega-3 fatty acids co-treated with (A) STS and (B)
H2O2 respectively for 48 hours. Trypan blue exclusion method was used to measure the cell 
viability. Graphs represent the mean ± S.E.M. for three independent experiments of control and 
treatment groups. Superscripted letters show significant differences between the treatments 
(p<0.05).
In H2O2 co-treated cells, almost similar trends in cellular response were found in all FA 
treatments. H2O2 treatment had a strong effect on NT2 cells reducing the cell viability
to half of that of the control. DHA, DPA and EPA supplementation were almost equally 
effective in increasing cell viability to approximately 90% to the control level. There 
was a significant difference in treatment efficacy between DHA and DPA (p< 0.01). But 
there were no significant differences either in between DHA and EPA or DPA and EPA 
treatments (Figure 1B).
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3.2. DHA and DPA and EPA pre-treatment increases NT2 cell viability
The effect of omega-3 fatty acids enrichment on cell viability were assessed after 48 
hours of exposure of NT2 cells to DHA, DPA and EPA following exposure with STS 
and H2O2 for further 48 hours. Cell viability was reduced to 60% in STS treatment 
compared to control. Each FA treatment increases the cell viability to approximately
85-95% from STS induced cell death (p<0.0001). DHA and EPA enrichment helped the 
cells to reach the viability almost to the level of control. There were no significant 
differences found either between DHA and EPA or between DPA and EPA treatments,
but the difference in the inhibition of cell death between DHA and DPA treatment was 
significant (p<0.01) (Figure. 2A).
Figure 2: Treatment of cells with omega-3 FAs improve cell viability against STS and 
H2O2 in pre-treatment
Cell viability assay showing the effects of pre-treatment of NT2 cells with omega-3 fatty acids 
for 48 hours following the exposure to (A) STS and (B) H2O2 for further 48 hours. Trypan blue 
exclusion method was used to measure the cell viability. Graphs represent the mean ± S.E.M. 
for three independent experiments of control and treatment groups. Superscripted letters show 
significant differences between the treatments (p<0.05).
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Pre-enrichment of cell with FAs following H2O2 exposure had revealed similar 
responses to those found in the pre-treatment with fatty acids following exposure with 
STS. Cell viability was reduced to almost 50% compared to control by H2O2 exposure. 
A significant increase in cell viability was observed in the treatment of DHA compared 
to cells exposed to H2O2 only (p<0.0001) (Figure. 2B). In this treatment group DHA
was shown to have higher increase in cell viability against H2O2 treatment
(approximately 90%) than DPA (approximately 75%) and EPA (approximately 85%) 
compared to control. The differences in efficiency in cell death prevention between FA
were not significant except between DHA and DPA (p<0.01) where DHA treatment was 
more efficient (Figure 2B). 
3.3. Omega-3 FAs protected NT2 cells from cytotoxic effects of STS and H2O2
In co-STS, where cells were co-treated with STS and FAs, it was found that almost 50% 
cells were dead in STS treatment death where in untreated control cell death was 
recorded at 3%. Individual treatments with DHA, DPA and EPA were shown to have 
equally significant inhibition of cell death induced by STS (P < 0.0001) and reduced the 
percentage of dead cells to or below the control level (Figure 3C).  
In co-H2O2, dead cell count was approximately 20% of the total cells when treated only 
with H2O2. DHA, DPA and EPA supplementation had shown a reduction in cell death 
in a chronological order of 12%, 13% and 15% respectively. DHA treatment showed
comparatively higher reduction in cell death than that of DPA and EPA treatments
(Figure 4C).
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Figure 3: Omega-3 FAs reduced cell death caused by STS in co-treatment
Flow cytometry analysis with propidium iodide (PI) showing reduction in dead NT2 cells when 
DHA and DPA and EPA were co-treated with STS. (A) Dot plots represent distribution of PI 
stained dead cells (red) and live cells (black) in each treatments (B) Overlay histogram 
represents accumulated live and dead cell count in each treatments with color coded lines. (C)
Bar graph represents dead cell count (% of PI stained cells) for subsequent treatments. Graphs 
represent the mean ± S.E.M. for three independent experiments of control and treatment groups. 
Superscripted letters show significant differences between the treatments (p<0.05).
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Figure 4: Omega-3 FAs reduced cell death caused by H2O2 co-treatment
Flow cytometry analysis with propidium iodide showing reduction in dead NT2 cells when 
DHA and DPA and EPA were co-treated with H2O2. (A) Dot plots represent distribution of PI 
stained dead cells (red) and live cells (black) in each treatments (B) Overlay histogram 
represents accumulated live and dead cell count in each treatments with color coded lines. (C)
Bar graph represents dead cell count (% of PI stained cells) for subsequent treatment. Graphs 
represent the mean ± S.E.M. for three independent experiments of control and treatment groups. 
Superscripted letters show significant differences between the treatments (p<0.05).
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In pre-treatment of cell with FA followed by STS treatment, approximately 50% cells 
were dead in STS treatment where in control observed dead cells were 9%. DHA pre-
enrichment reduced cell death to approximately 15%, which was significantly different 
compared to STS (p< 0.0001). DPA and EPA enrichment had also reduced the 
percentage of dead cells to a significant level to approximately 20% and 17% 
respectively (Figure 5C). 
The cytotoxic effect of H2O2 treatment on the cells was also evident showing
approximately 35% dead cells. FA supplementation had shown a significant effect on 
reducing cell death and observed with 18%, 24% and 25% dead cells by DHA, DPA 
and EPA treatment respectively (p< 0.0001) (Figure 6C).
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 Figure 5: Omega-3 FAs reduced cell death induced by STS in pre-treatment
Flow cytometry analysis with propidium iodide showing reduction in dead NT2 cells when pre-
treated with DHA and DPA and EPA followed by STS treatment. (A) Dot plots represent 
distribution of PI stained dead cells (red) and live cells (black) in each treatments (B) Overlay 
histogram represents accumulated live and dead cell count in each treatments with color coded 
lines. (C) Bar graph represents dead cell count (% of PI stained cells) for subsequent treatments.
Graphs represent the mean ± S.E.M. for three independent experiments of control and treatment 
groups. Superscripted letters show significant differences between the treatments (p<0.05).
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Figure 6: Omega-3 FAs reduced cell death induced by H2O2 in pre-treatment
Flow cytometry analysis with propidium iodide showing reduction in dead NT2 cells when pre-
treated with DHA and DPA and EPA followed by H2O2 treatment. (A) Dot plots represent 
distribution of PI stained dead cells (red) and live cells (black) in each treatments (B) Overlay 
histogram represents accumulated live and dead cell count in each treatments with color coded 
lines. (C) Bar graph represents dead cell count (% of PI stained cells) for subsequent treatments.
Graphs represent the mean ± S.E.M. for three independent experiments of control and treatment 
groups. Superscripted letters show significant differences between the treatments (p<0.05).
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3.4. Analysis of expression of molecular marker of apoptosis:
Western blot analysis was carried out to detect pro-apoptotic marker protein BAX. In 
co-STS cells, an almost 40% increase in BAX expression was found compared to 
control in cells treated only with STS (p< 0.0001). Co-treatment of cells with FAs
helped reduce the BAX expression. BAX expression was reduced by almost 30% from 
the level of STS (p< 0.01) in DHA treated cells. DPA and EPA treatment also helped 
reduce the BAX but they were not as effective as DHA (Figure 7A). 
In co-H2O2, BAX was increased by almost 30% compared to control and was reduced 
down to control level when co-treated with DHA (p<0.01) and EPA (p< 0.01). DPA had 
also reduced the BAX but it was not significant compared to DHA and EPA (Figure
7B).
Figure 7: The effect of omega 3 fatty acids co-treatment on STS and H2O2 induced BAX
expression
Results of western blot showing the expression of pro-apoptotic marker BAX when NT2 cells 
were co-treated with omega-3 fatty acids following (A) STS and (B) H2O2. Graphs represent 
the mean ± S.E.M. for three independent experiments of control and treatment groups. 
Superscripted letters show significant differences between the treatments (p<0.05).
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In pre-STS treatment group BAX expression was increased by approximately 40% by 
STS treatment relative to the control (Figure 8A). BAX expression was reduced by 
approximately 20% relative to STS when the cells were pre-treated with DHA (p<
0.05). There were no significant effect of DPA and EPA pre-treatment in reducing BAX 
expression (Figure 8A).
Figure 8: The effect of omega 3 fatty acids pre-treatment on STS and H2O2 induced BAX 
expression
Western blot results showing the expression of pro-apoptotic marker BAX when NT2 cells are 
pre-treated with free DHA and DPA and EPA followed treatment with (A) staurosporine and 
(B) H2O2. Graphs represent the mean ± S.E.M. for three independent experiments of control 
and treatment groups. Superscripted letters show significant differences between the treatments 
(p<0.05).
On the other hand, in pre-H2O2 treatment group, in H2O2 treated cells increase in BAX 
expression was 40% higher comparative to control. The only effective treatment 
observed was with DHA that reduced the BAX by approximately 20% to that of H2O2
treatment (Figure 8B). EPA enrichment resulted with reduction of BAX expression but 
its effect was not significant. DPA had almost no effect on the reduction of BAX 
compared to that of H2O2 (Figure 8B).
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4. DISCUSSION
The preliminary aim of this study was to verify whether DPA (22:5n-3) and EPA
(20:5n-3) have similar anti-apoptotic effects as DHA (22:6n-3) when tested in the 
neuronal cell models. In the previous study a significant inhibitory effect of DHA-FFA
and DHA-PLs on neuronal cell death was observed. Results from this study demonstrate 
a strong anti-apoptotic property of all n-3 omega FAs, especially DHA, showing a
prominent effect against STS and H2O2 induced cell death. Differences in efficiency of 
these FA against STS and H2O2 may indicate their participation in different pathways 
involved in STS and H2O2 induced apoptosis that were described in chapter 2. Results 
from the present study are in agreement with experimental evidences demonstrating the 
efficacy of n-3 PUFAs in resisting neuronal apoptosis thus proving their neuroprotective 
potential are described below 
A previous study of mouse neural progenitor cells (NPCs) reported that n-3 PUFAs 
especially DHA and EPA have a significant protective effect against H2O2-induced 
oxidative injury. FA pre-treatment of NPCs for 2 hours prior H2O2 exposure 
significantly induced the expression of nuclear factor erythroid 2-related factor 2 (Nrf2).
Nrf2 is a nuclear transcription regulatory protein, which is very important in inducing 
the expression of anti-oxidant genes and resist intra- or extra-cellular oxidative stress
(Kensler et al., 2007; Liu et al., 2014; Ma, 2013). Omega-3 FAs treatment showed 
inhibition of cell death caused by H2O2 exposure in both co and pre-treatment that may 
share the function by reducing ROS into the cellular environment.
In another report it was demonstrated that omega-3 fatty acids have the capacity to 
suppress oxidative stress in cultured neurons and mouse neuronal progenitor cells. 
These treatments had markedly reduced the level of reactive oxygen species (ROS) and 
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suppressed apoptosis successfully. It was also demonstrated that omega-3 treatment 
noticeably reduced caspase-3 activation levels and poly (ADP-ribose) polymerase-1
(PARP1) cleavage, which are preliminary indicative measures of apoptosis (Kim et al., 
2010). Experimental results in this study demonstrating anti-apoptotic ability of all three 
PUFAs also in agreement with the above observations. 
Dietary n-3 PUFAs are significantly incorporated into membrane phospholipids and 
increase the total phospholipid pool within the cell membrane. FA supplementation also 
contribute to reduce the levels of arachidonic acid (AA) in the cell membrane (Calviello 
et al., 1999; de Pablo & Alvarez de Cienfuegos, 2000; Nettleton, 1995; Pittet et al., 
2010). AA is produced from the activation of phospholipase A2 (PLA2) through 
mitochondrial Ca2+ dependent pathway, further metabolized by lipoxygenases or 
cyclooxygenases causing generation of ROS and subsequently lead to cellular apoptosis 
(Miller et al., 1992; Orrenius et al., 2003; Penzo et al., 2004; Zhivotovsky & Orrenius, 
2011) Reduction in AA content as a consequence of FA supplementation demonstrate 
their anti-apoptotic mechanism. In this experiment, inhibition of induced apoptotic cell 
death by FA treatments may indicate their involvement in these particular anti-apoptotic 
pathway.
It was also shown that DHA and EPA have anti-apoptotic effect examined in a neuronal 
cell line, Neuro2A against chemically induced apoptosis, including treatment with 
etoposide, okadaic acid by releasing the enzyme lactate dehydrogenase (LDH), which
involve in inducing apoptosis in Neuro2A cells. The anti-apoptotic effects of these FAs 
were observed as reduced DNA fragmentation as well as reduced LDH and caspase-3
activity (Wu et al., 2007). Whether the anti-apoptotic effect was unique for DHA 
enrichment, the effects of other fatty acids, e.g.: arachidonic acid (AA) and oleic acid 
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(OA) were examined in staurosporine-induced apoptosis in Neuro2A cells.  Significant 
inhibition of caspase-3 activity was observed only in DHA-enriched cells but not in OA 
and AA-enriched cells (Akbar & Kim, 2002). For this experiment DPA and EPA was 
used (as other FAs was already in experimentally implied) to compare their anti-
apoptotic properties to that of DHA. Outcomes of this study reflected the consequences 
of above stated and showed better inhibitory effect by DHA treatment than that of DPA 
and EPA against induced apoptosis.
Studies on n-3 FA uptake and incorporation suggested that DHA and EPA is highly 
specific in incorporation into membrane (Pittet et al., 2010) and plasma phospholipids 
(Schuchardt et al., 2011). The bioavailability of these FAs also depends on their forms 
(eg: free FA or ethyl ester) during supplementation (Dyerberg et al., 2010; Galli et al., 
2012; Nordoy et al., 1991).  It was found that EPA has a preference to be incorporated
into membrane PC and PE of platelet (Popp-Snijders et al., 1986) whereas the DHA 
preferentially was found to increase in the PS fraction, which was described previously 
to successfully inhibit the STS, induced apoptosis (Akbar & Kim, 2002). This criterion
of selective incorporation of n-3 FAs into membrane phospholipid may play the role of 
difference in the inhibitory effect of FAs treatment against apoptotic cell death.
In the previous chapter, association of the Bcl-2 family BAX protein was described as
one of the potent regulators of apoptosis (Chipuk et al., 2012; Tait & Green, 2010). It
has been shown that DHA enrichment significantly reduced the BAX expression in an 
investigation where the possible contribution of n-3 FAs regulating neuronal apoptosis 
during brain development in a rat model of hypothyroidism-induced neuronal apoptosis
was conducted. Significant reduction in DNA fragmentation and caspase-3 activation in 
developing cerebellum of hypothyroid pups was observed. There was also a significant 
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reduction of pro-apoptotic BAX and increase in anti-apoptotic BCL-2 prominent in 
DHA and EPA supplemented pregnant rats followed by induction of hypothyroidism by 
administering methimazole, an antithyroid agent that inhibits the production of thyroid 
hormone. Perinatal hypothyroidism in rat is observed with increased neuronal 
apoptosis in the developing cerebellum, that’s why pregnant rat was used as an 
experimental model in this experiment (Sinha et al., 2009). In this current study the 
expression of pro-apoptotic marker BAX protein was investigated against n-3 FA 
treatments. Significant reduction of STS and H2O2 induced BAX expression by 
supplementing NT2 cells with DHA, DPA and EPA were observed in this study which 
coincide with the findings of Sinha et al.
Involvement of DPA (22:5n-3) in health and wellbeing to a similar extent of EPA 
(20:5n-3) and DHA (22:6n-3) was confirmed by epidemiological studies (Byelashov et 
al., 2015). The inhibitory effects of docosapentaenoic acid on STS induced neuronal 
apoptosis was also demonstrated (Kim. et al., 2003). In this study, DHA, DPA and EPA 
had an almost equal potential effect against neuronal cell death. This similarity in 
effectiveness may be explained by the fact of sharing structural similarities between 
them. DHA is a primary metabolite of EPA and DPA (Kelly et al., 2011). There is also 
a provision of retro conversion of DPA to EPA (Cutler et al., 2004; Kaur et al., 2010),
which can alter their effect in different culture condition. The differences in potential 
activity of these n-3 FAs in neuroprotection may be due to the difference in uptake 
mechanism of individual n-3 FAs into membranes.
In this study, comparison of pre-supplementation and co-treatment of NT2 cells with 
DHA, DPA and EPA, in conjunction with cell death-inducing agents is a unique 
observation. The co-treatment paradigm provided with higher efficiency of 
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supplemented PUFAs in the inhibition of neuronal apoptosis compared with the pre-
treatment approach. The reason could be explained as the presence of extracellular 
PUFAs in the incubation medium during the exposure to STS and H2O2 that may be
internalized during the treatment period of the cell, and thus provide more protection to 
the cells against apoptosis inducing agents which was also evident in the previous study 
(chapter 2). This observation may demonstrate a better beneficial effect of co- treatment 
of DHA, DPA and EPA against apoptotic neuronal cell death over pre-treatment 
paradigm. Moreover, individual treatment with theses fatty acids or in combination may 
provide a potential mean of treating diseased neuronal conditions.  
5. CONCLUSION
This experiment showed that DHA, DPA and EPA have beneficial effects in increasing 
cell viability and reducing cell death against neuronal cell death induced by STS and 
H2O2. On the other hand the studies of BAX expression revealed DHA had a better
protective effects than the other FAs. In pre-treatment, fatty acids were less effective in 
regulating BAX expression than they were observed to be in co-treatment paradigm.
The results suffered from variability between experiments, which limited the ability to 
determine the full extent of these effects.
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CHAPTER 4
Investigation of nanoliposomal DHA
in preventing apoptotic cell death and 
analysis of cellular lipid accumulation
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ABSTRACT
Nanoliposomal DHA was examined against neuronal cell death in the NT2 cell line 
induced by staurosporine and hydrogen peroxide in a co-treatment and pre-treatment 
paradigm to compare the efficacy of 10 μg/ml free DHA, free nanoliposome and 
nanoliposomal DHA, particularly milk fat globule membrane (MFGM), MFGM-DHA, 
soy and soy-DHA against induced neuronal cell death. Cellular responses from two 
different treatment paradigms indicated inhibitory effects of all these treatments apart 
from MFGM. Among all the treatments, free DHA indispensably showed significant
increase in cell viability as well as reduced cell death up to control level against 
neuronal apoptosis than any other treatments. Lipidomic study also demonstrated 
higher increase (500-1200%) of major phospholipids such as lysophosphatidylcholine 
(LPC), Phosphatidylcholine (PC), phosphatidylethanolamine (PE) and 
phosphatidylinositol (PI) as well as DHA containing cellular phospholipids by the 
treatment of free DHA than that of nanoliposomes and nanoliposomal DHA.  These 
results may conclude the beneficial use of free DHA as a preventable treatment 
alternative for the disease caused from neuronal apoptosis.
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1. INTRODUCTION
Nanoliposomes are utilised used as drug delivery system in clinical practice, following 
their development over the last few decades (Gregoriadis, 1976). Liposomes have
proven use for targeted delivery of bioactive compounds to the site of action in clinical 
studies and are promising for improving the solubility of many amphiphilic drugs
(dD÷GDú HW DO ; Gowda et al., 2013; Lian & Ho, 2001; Mufamadi et al., 2011).
Nanoliposomes are nano-sized, non-toxic and biocompatible, artificial vesicles. It is
composed of lipid bilayers with an aqueous phase inside and between the lipid bilayers
differing in their lipid composition, method of preparation, size, permeability, charge 
density and steric hindrance (Akbarzadeh et al., 2013; Bawarski et al., 2008; Malam et 
al., 2009; Pattni et al., 2015). Based on the type of vesicle, liposomes are characterized 
as multilamellar vesicles (size 500-5000 nm), small unilamellar vesicles (around 100 
nm) and large unilamellar vesicles (200-800 nm) (Torchilin, 2005). Liposomes has a 
dual carrier feature that can carry both hydrophobic or lipophilic and hydrophilic drugs 
which are encapsulated in their membrane phospholipid and aqueous core respectively 
(Akbarzadeh et al., 2013; Bozzuto & Molinari, 2015; dD÷GDúHWDO; Mufamadi et 
al., 2011; Yoshikawa et al., 2015). A simplified diagram of nanoliposome packed with 
lipophilic and hydrophilic drugs is depicted in Figure 1 (Gowda et al., 2013).
Drug delivery across the BBB (Juillerat-Jeanneret, 2008) by nanoliposomes has been 
substantially increased in recent years because of their unique properties described 
above. 
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Figure 1: Nanoliposomal preparation for drug delivery. Modified from (Gowda et al., 
2013)
A characteristic biological composition of these nanoliposomes were previously 
discussed. MFGM derived liposomes are usually composed of several classes of 
Phospholipids including phosphatidylcholine (PC), photidylethanolamine (PE),
sphingomyelin (SM), phosphatidylserine (PS) and phosphatidylinositol (PI) (Astaire et 
al., 2003; Boyd et al., 1999; Thompson et al., 2006). Liposomes derived from soy 
phospholipids are also composed of PC, PE and PI but lack in PS and SM (Thompson 
et al., 2006). Nanoliposomes derived from phospholipid fraction of MFGM and soy 
were also engineered with internalised DHA and used in this study to determine if they 
contribute to increase neuronal cell survival by promoting DHA uptake in an apoptotic 
environment. Among several sources, nanoliposomes prepared from milk fat globule 
membrane (MFGM) phospholipid fraction and from soy phospholipid were chosen for 
their low production cost and lower toxicity to the cell for their unique properties for 
improved drug delivery as well. MFGM fractions have been successfully used for the 
delivery for their emulsifying properties that enhances the drug delivery (Roesch et al., 
2004). Presence of high proportion of phospholipid material particularly, sphingolipids
Page | 116  
 
in MFGM also increase their suitability for the clinical use. On the other hand 
liposomes prepared from soy phospholipids have strong charge repulsion that may 
protect soy phospholipid liposome dispersions from aggregating in different pH
solution (Thompson et al., 2006). Considering all these beneficial properties of selected 
nanoliposome, the main purpose of this study is to determine if the nanoliposomal DHA 
contribute to increase neuronal cell survival by promoting DHA uptake in an apoptotic 
environment.
2. MATERIALS AND METHODS
2.1 Preparation of the Nanoliposomes
MFGM liposomes were prepared commercially from industrial dairy waste (buttermilk) 
by the methods described previously in (Corredig et al., 2003; Thompson et al., 2006;
Thompson & Singh, 2006). Briefly A phospholipid-rich fraction (Phospholac 600) was 
derived from MFGM (Fonterra Cooperative Group Ltd. New Zealand) that contained 
approximately 83% lipid, 6.2% lactose, 11.5% ash, and 2.6% moisture. A purified soy 
phospholipid fraction that contained minimum 30% phosphatidylcholine (Sigma-
Aldrich, St. Louis, MO) also used in the preparation. The lipid was extracted from the 
phospholipid fraction using chloroform and methanol in a ratio of 1:2 (by volume). 
Fatty acids were then methylated in a sealed tube by acid-catalyzed transesterification 
at 80°C for 12 hours. Later on the fatty acid methyl esters were separated using a gas 
chromatographic system. For preparing liposome dispersions, A 10% lipid dispersion 
was made in imidazole buffer (20 mM imidazole, 50 mM sodium chloride, and 0.02%
sodium azide in Milli-Q water, adjusted to pH 7, with 1 M HCl) and thoroughly mixed 
using an Ultra-Turrax blender (JKA, Staufen, Germany). The phospholipid dispersion 
was then processed using an M-110Y Microfluidizer (Microfluidics International Corp., 
Newton, MA). After preparation, their potential as liposomes were measured for their 
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phospholipid head groups, lipid dispersion, zeta potential, average hydrodynamic 
diameter and their possible phospholipid oxidation to confirm their active properties.
2.2 Cell Culture and Treatment
Neuronally committed teratocarcinoma NT2 cells (NTERA-2 cl.D1 [NT2/D1] 
ATCC® CRL-1973) were used as a model cell line in this study. STS was purchased 
from Enzo Life Sciences, Inc. Farmingdale, NY-11735, USA. H2O2 was purchased from 
$MD[)LQHFKHP7KHUPR)LVKHU6FLHQWL¿F6FRUHVE\9,&-3179, Australia. The cells were 
routinely maintained in 1:1 (v/v) mixture of DMEM high glucose (Life Technologies) 
and nutrient mixture F-12 (Life Technologies) supplemented with 10% (vol/vol) foetal 
bovine serum (Gibco BRL, Grand Island, NY, USA), 1X uridine and kept at 37°C in a 
tissue culture incubator with 5% CO2 and 98% relative humidity. The cells were seeded 
in T-75 tissue culture flasks and cultured maintained for their growth. Exponentially 
growing cells were used throughout the experiments. NT2 cells were pre-treated with 10 
μg/ml of DHA-FFA, free nanoliposomes (MFGM, soy) and DHA-nanoliposomes
(MFGM-DHA, soy-DHA) for 48 hours, followed by exposure to 10nM of STS and 
300μM of H2O2 for 48 hours to study their effects on apoptosis. To assess the role of 
DHA in the cell rescue, ȝJPO of free DHA, free nanoliposomes and DHA-
nanoliposome were co-treated with 10nM of STS or 300μM of H2O2 for 48hours. The 
cellular responses were measured by a cell viability assay and confirmed by western 
blot using the pro-apoptotic marker BAX antibody (ABcam, USA).
2.3 Cell viability count
Cells were seeded in 12 welled cell culture plate prior STS and H2O2 treatment and 
incubated in normal cell culture condition described in cell culture technique. Next day 
the cells were treated with subsequent treatment and incubated for 48 hours. After 48 
Page | 118  
 
hours cells were washed with PBS and trypsinized with 0.05% Trypsin EDTA. Cells 
were then harvested and resuspended in complete culture medium. Viable cell numbers
were counted by Countess™ Automated Cell Counter (Invitrogen, Carlsbad, California, 
USA) using 1:1 ratio of cell suspension and trypan blue. Only the live cells observed 
were taken into consideration and graphed using Graphpad Prism 6 software 
(GraphPad Software, Inc. La Jolla, CA 92037 USA). 
2.4 Western blot analysis
A concentration of ȝJPO'+$-FFA, nanoliposomes and DHA- nanoliposomes were 
used to treat NT2 cells seeded in T-25 flasks. 10 nM STS and 300 μm H2O2 were 
applied for 48 hours along with or after the DHA and nanoliposomes supplementation. 
After the treatments cells were harvested and treated with 2% SDS cell lysis buffer (10-
mM EDTA, 50-mM Tris-base, pH 8.0) and sonicated for 30 Sec. Protein concentrations 
were measured using the BCA protein assay kit (ThermoFisher, Australia). Briefly, 50-
ȝJ VDPSOHV RI SURWHLn were loaded on 15% SDS-PAGE gels and run for protein 
separation, transferred to nitrocellulose PHPEUDQHV ȝP0LOOLSRUHDQGEORFNHG
with 5% non-fat milk in TBST buffer (20-mM Tris–HCl, 120-mM NaCl, 0.1% Tween-20) 
for 1 hour. The membrane was then incubated overnight at 4o C with primary antibody 
ȕ-actin in a ratio of 1:5000 and BAX in a ratio of 1:10007KHPRXVHPRQRFORQDOȕ-
actin antibody were purchased from Sigma, rabbit polyclonal BAX antibody were 
purchased from ABcam. After three washes (5 min each) with TBST (TBS containing 
0.1% Tween-20), the membranes were incubated with subsequent horseradish 
peroxidase-conjugated secondary antibody in a ratio of 1:2000 (Merck Millipore, 
Australia) for 1 hour at room temperature. After three washes (5 min each) with TBST, 
proteins were visualized using the enhanced chemiluminescence method (Immobilon 
Western, Millipore Corporation, Billerica, MA, 01821, USA) and membrane images 
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were taken by Chemidoc MP System (Bio-Rad, California, USA). The protein 
expresVLRQOHYHOVZHUHQRUPDOL]HGWRWKHH[SUHVVLRQRIKRXVHNHHSLQJJHQHȕ-actin and 
H[SUHVVHGLQSHUFHQWDJHUHODWLYHWRWKHH[SUHVVLRQRIȕ-actin (Sigma-Aldrich, USA).
2.5 Flow cytometry analysis
NT2 cells were seeded and cultivated in 12 well plates at 37 °C and 5% CO2 in 
complete DMEM media (Life Technologies) supplemented with F-12 (Life 
Technologies), 10% FBS (Life Technologies) and 1X Uridine (Sigma). Cells were 
treated with cell death inducing agents STS and H2O2 along with DHA free 
nanoliposomes and DHA-nanoliposome for 48 hours. Cells were then harvested by 
trypsinization, diluted into the complete medium and transferred them into the FACS 
tubes immediately. Cells were centrifuged at 1000 rpm for 5 min at 4°C and the 
supernatant were aspirated. Propidium iodide (5μg/ml) in PBS was added to each 
individual sample and analysed by flow cytometry (BD FACS Canto™ II, BD 
Biosciences). Acquired data were analysed by Flowing Software (Turku Bioimaging, 
University of Turku, Finland) 
2.6 Preparation of cell lysates for mass spectrometry
Cell lysates were prepared by following the standard operating procedure of Baker IDI 
Heart and Diabetes Institute, Melbourne, Australia for preparation of cell lysates for 
mass spectrometry. Cells were collected after individual treatment in a microcentrifuge 
tube as a pellet and stored at -800 C until the further use. Cell pellets were resuspend in 
200μl Tris-NaCl (0.5M of NaCl and 0.02M of Tris) at pH to 7.4 and transferred to 
1.5ml Eppendorf tube. Butylated hydroxytoluene (BHT ȝO) ȝ0added to each 
tube. Individual cell suspensions were sonicated on ice for 5-10 seconds at 25% 
amplification using a digital Misonix Probe Sonifier (LabX, Canada) until the cell 
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suspension became transparent. Protein concentrations in each cell lysate were
determined using the BCA™ kit (Thermo scientific) according to the manufacturer’s 
protocol. The remainder of the lysate was used for lipid extraction.
2.7 Lipid extraction and lipidomic analysis
Lipid extraction was performed using a modification of the Folch method (Folch et al., 
1957). Briefly, an internal standard mixture, containing between 50-1000 pmol of 23 
non-physiologic and stable isotope-labelled lipids, was added to the randomized and 
sonicated cellular extracts. The lipids from cell lines were extracted with 
chloroform:methanol (2:1, 20 volumes), mixed, sonicated for 30 min to assist the 
liberation of lipids from the proteins and allowed to stand for 20 min. Samples were 
centrifuged (16000g, 10 min) and the supernatant transferred to a 96 well plate and 
dried under a stream of nitrogen at 40 °C. Immediately before analysis, samples were 
reconstituted in water saturated butanol and sonicated for 10min followed by addition of 
methanol containing 10 mM ammonium formate (Sigma Aldrich). Samples were 
centrifuged (5000g, 10 min) and transferred to glass vials.
Lipidomic analysis was performed by HPLC, electrospray ionization-tandem mass 
spectrometry by using an Agilent 1200 liquid-chromatography system combined with a 
Biosystems API 4000 Q/TRAP mass spectrometer with a turbo-ionspray source (350°C) 
(AB SCIEX, USA) and Analyst 1.5 data system (AB SCIEX, USA). Over 300 individual 
lipid species were analyzed by multiple reaction monitoring (MRM) experiments. 
Individual species in each lipid class were summed for statistical evaluation.
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2.8 Statistical analysis
Statistical significances between treatments were determined using one-way ANOVA 
(Tukeys method) with the GraphPad Prism software (Version 6.07) (GraphPad 
Software, Inc. La Jolla, CA 92037 USA). Unless otherwise stated, the graphs shown 
here represent the mean ± S.E.M. for three independent experiments of control and 
treatment groups and P<0.05 was considered as statistically significant.
3. RESULTS
DHA-FFA, two individual nanoliposomes derived from milk fat globule membrane 
(MFGM) and soy and DHA incorporated into these two nanoliposomes (MFGM-DHA, 
soy-DHA) were used in this study to treat the NT2 cells in co and pre-treatment 
paradigms with STS and H2O2.
3.1. DHA-FFA, nanoliposomes and DHA-nanoliposomes increase cell viability in 
co-treatment with STS and H2O2
NT2 cells were exposed to DHA-FFA, MFGM, MFGM-DHA, soy and soy-DHA
nanoliposomes to assess their effect on cell viability in the presence of STS and H2O2
for 48 hours. Increase in cell viability was observed following all these treatments. In 
co-STS, cell viability was decreased by STS treatment to almost 50% relative to the 
control. Apart from MFGM all other treatments were equally inhibited of cell death and 
cell viability was almost at the level of control. (Figure 2A).
In co-H2O2 on the other hand, a lower viable cells were observed in H2O2 treatment 
reducing the cell viability down to 30% relative to that of control. Apart from soy and 
soy-DHA, cell viability was increased up to the control level in all treatments, which
were higher than that of H2O2 treatment (Figure 2B). 
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Figure 2: DHA-FFA, nanoliposomes and DHA-nanoliposomes improve cell viability in co-
treatment
Cell viability assay showing the effect of DHA-FFA and DHA nanoliposomes on cells co-
treated with (A) STS and (B) H2O2 respectively for 48 hours. Trypan blue exclusion was used 
to measure the cell viability. Graphs represent the mean ± S.E.M. for three independent 
experiments of control and treatment groups. Superscripted letters show significant differences 
between the treatments (p<0.05).
3.2. DHA-FFA, nanoliposomes and DHA-nanoliposomes improve cell viability in 
pre-treatment
Cell viability was assessed after 48 hours of exposure of NT2 cells to DHA-FFA, 
nanoliposomes and DHA-nanoliposomes followed by the exposure with STS and H2O2
for a further 48 hours. In STS treatment group, a significant increase in cell viability to 
almost control level in DHA-FFA treatment compared to the cells treated with STS 
(p<0.01) was observed. Nanoliposomes and DHA-nanoliposomes also increased cell 
viability in apoptotic condition. MFGM-DHA and soy-DHA showed higher increase in 
cell growth than that of DHA-FFA and other treatments. DHA-FFA and DHA-
nanoliposome were shown to inhibit the adverse effect of STS on NT2 cells (p<0.05).
There were almost no significant difference found between the efficiency of DHA-FFA, 
nanoliposomes and DHA-Nanoliposomes (Figure 3A). 
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Figure 3: DHA-FFA, nanoliposomes and DHA-nanoliposomes improve cell viability in 
pre-treatment
Cell viability assay showing the effects of pre-treatment with DHA and nanoliposomes for 48 
hours followed by the treatment with (A) STS and (B) H2O2 for further 48 hours. Trypan blue 
exclusion method was used to measure the cell viability. Graphs represent the mean ± S.E.M. 
for three independent experiments of control and treatment groups. Superscripted letters show 
significant differences between the treatments (p<0.05). 
Cell viability was recorded to a level below approximately 50% in H2O2 treatment to
that of the control. Although all the treatments were found almost equally efficient in 
increasing the viability to the control level, the highest response against H2O2 was 
found in MFGM-DHA and soy-DHA treatment (p<0.0001). There were no significant 
difference in viability increased by the treatment of nanoliposomes and DHA-
nanoliposomes (Figure 3B)
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3.3. DHA-FFA, nanoliposomes and DHA-nanoliposomes protected NT2 cells from 
cytotoxic effects of STS and H2O2
Propidium iodide (PI) is a membrane impermeable dye used to assess the cytotoxic 
effects of cell death-inducing agents and was used to establish the effects of DHA-FFA, 
nanoliposomes and DHA-nanoliposomes in preventing cell death. In co-STS treatment, 
STS induced cell death was counted to approximately 40% of total cell. Separate 
treatment with DHA and nanoliposomes except MFGM displayed significant increase 
in cell viability compared to STS and reduced the percentage of dead cells to or below 
the control level.  DHA-FFA and soy-DHA appeared to be more effective in reducing
cell death compared to STS (p< 0.0001). Interestingly, MFGM treatment had induced 
the cell death even higher than that of STS treatment and cell death recorded was 60% 
of total cells (Figure 4C).
Similarly, in co- H2O2 treatment, H2O2 had triggered cell death close to 40% (Figure 5). 
All the treatments were equally effective in reducing cell death closer to the control 
level apart from MFGM treatment, which appeared to be less effective in increasing cell 
viability against H2O2, induced cell death (Figure 5C).
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Figure 4: DHA-FFA, nanoliposomes and DHA-nanoliposomes reduced cell death induced
by STS co-treatment
Flow cytometry analysis with propidium iodide showing reduction in dead cells of NT2 when 
DHA-FFA, nanoliposomes and DHA-nanoliposomes were co-treated with STS. (A) Dot plots 
represent % of PI stained dead cells (red) and live cells (black) in each treatments (B) Overlay 
histogram represents accumulated live and dead cell count in each treatments with colour coded 
lines. (C) Bar graph represents dead cell count (PI stained cells in %) for subsequent treatments.
Graphs represent the mean ± S.E.M. for three independent experiments of control and treatment 
groups. Superscripted letters show significant differences between the treatments (p<0.05).
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Figure 5: DHA-FFA, nanoliposomes and DHA-nanoliposomes reduced cell death induced
by H2O2 co-treatment
Flow cytometry analysis with propidium iodide showing reduction in dead cells of NT2 when 
DHA-FFA, nanoliposomes and DHA-nanoliposomes were co-treated with H2O2. (A) Dot plots 
represent % of PI stained dead cells (red) and live cells (black) in each treatments (B) Overlay 
histogram represents accumulated live and dead cell count in each treatments with colour coded 
lines. (C) Bar graph represents dead cell count (PI stained cells in %) for subsequent treatments.
Graphs represent the mean ± S.E.M. for three independent experiments of control and treatment 
groups. Superscripted letters show significant differences between the treatments (p<0.05).
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In pre-STS treatment group, approximately 50% of dead cells compared to control were 
detected following STS treatment (Figure 6). Pre-treatment with DHA-FFA, MFGM-
DHA, soy and soy-DHA were found equally effective in reducing cell death and the 
dead cell count was recorded to approximately 20%. MFGM treatment was also able to 
reduce the percentage of cell death but was less effective than other treatments (Figure 
6C).
In pre-H2O2 treatment group, cytotoxic effect of H2O2 on the NT2 cells was shown
with a dead cell count of approximately 60% (Figure 7). All the DHA-FFA, 
nanoliposomes and DHA- nanoliposomes supplementation had shown inhibitory effect 
and reduced cell death down to 35-30% against the effect of H2O2 treatment (p<
0.0001). In this instance, all individual treatments were almost equally effective in 
reducing cell death induced by H2O2 treatment (Figure 7C).
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Figure 6: DHA-FFA, nanoliposomes and DHA-nanoliposomes reduced cell death induced
by STS in pre-treatment
Flow cytometry analysis with propidium iodide showing reduction in dead cells of NT2 when 
pre-treated with DHA-FFA, nanoliposomes and DHA-nanoliposomes followed by STS 
treatment. (A) Dot plots represent % of PI stained dead cells (red) and live cells (black) in each 
treatments (B) Overlay histogram represents accumulated live and dead cell count in each 
treatments with colour coded lines. (C) Bar graph represents dead cell count (PI stained cells in 
%) for subsequent treatments. Graphs represent the mean ± S.E.M. for three independent 
experiments of control and treatment groups. Superscripted letters show significant differences 
between the treatments (p<0.05).
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Figure 7: DHA-FFA, nanoliposomes and DHA-nanoliposomes reduced cell death induced
by H2O2 in pre-treatment
Flow cytometry analysis with propidium iodide showing reduction in dead cells of NT2 when 
pre-treated with DHA-FFA, nanoliposomes and DHA-nanoliposomes followed by H2O2
treatment. (A) Dot plots represent % of PI stained dead cells (red) and live cells (black) in each 
treatments (B) Overlay histogram represents accumulated live and dead cell count in each 
treatments with colour coded lines. (C) Bar graph represents dead cell count (PI stained cells in 
%) for subsequent treatments. Graphs represent the mean ± S.E.M. for three independent 
experiments of control and treatment groups. Superscripted letters show significant differences 
between the treatments (p<0.05).
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3.4. DHA-FFA, nanoliposomes and DHA-nanoliposomes reduced the expression of 
pro-apoptotic marker BAX protein
Pro-apoptotic BCL-2-associated X protein (BAX) is a major apoptosis regulatory 
protein. Western blot analysis was carried out to detect the levels of BAX protein. In co-
STS, it was evident that the expression of pro-apoptotic marker BAX was increased by 
up-to 40% compared to the control when NT2 cells were treated only with STS 
(p<0.0001). In DHA-FFA treatment, BAX was reduced to the control level. 
Nanoliposomes and DHA-nanoliposomes were also equally effective as DHA in 
reducing the expression of BAX to the control level differing only in significance level 
(Figure 8A). 
In co-H2O2, cell treated with only H2O2 had 40% increased level of BAX compared to 
control. BAX was reduced closer to the control level by treating the cells with DHA-
FFA (p<0.05). MFGM (p<0.01) and MFGM-DHA (p<0.05) had increased efficiency in 
reducing BAX than DHA-FFA and other nanoliposomes do. Soy and soy-DHA were not 
effective in the reducing of BAX expression in this particular case (Figure 8B).
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Figure 8: The effect of DHA and nanoliposomes on STS and H2O2 induced BAX 
expression:
Results of western blot showing the expression the expression of pro-apoptotic marker BAX 
when NT2 cells were Co-treated with DHA and Nanoliposomes and (A) Staurosporine, (B)
H2O2. The graphs represent the mean ± S.E.M. for three independent experiments of control 
and treatment groups. Superscripted letters show significant differences between the treatments 
(p<0.05).
In pre-treatment group where NT2 cells were supplemented with DHA-FFA,
nanoliposomes and DHA-nanoliposomes following exposure to STS, interestingly a 
different response pattern was observed than from co-STS treatment. The only effective 
treatment in this pre-treatment paradigm was DHA-FFA that has shown to decrease the 
BAX closer to control level compared to STS (p<0.05). Treatment with empty 
nanoliposomes and DHA-nanoliposomes were found less effective in reducing the BAX 
expression (Figure 9A).
There was a 50% increased BAX by H2O2 treatment relative to the control. DHA-FFA 
and MFGM-DHA treatment reduced BAX by approximately 25% relative to the cells 
treated with H2O2 alone. Rest of the treatments including MFGM, soy and soy-DHA 
were found less efficient in reducing the BAX expression (Figure 9B).
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Figure 9: The effect of DHA and nanoliposomes pre-treatment on STS and H2O2 induced 
BAX expression:
Western blot results showing the expression of pro-apoptotic marker BAX when NT2 cells were 
pre-treated with DHA and nanoliposomes followed by the treatment with (A) staurosporine and 
(B) H2O2. The graphs represent the mean ± S.E.M. for three independent experiments of control 
and treatment groups. Superscripted letters show significant differences between the treatments 
(p<0.05). 
3.5. DHA-FFA, nanoliposomes and DHA-nanoliposomes treatment alter the 
abundance of DHA containing phospholipids in NT2 cells
From the lipidomics study of DHA-FFA and DHA-nanoliposomes treated NT2 cells in 
both pre- and co-treatment paradigms with STS and H2O2, substantial changes in lipid 
profile of NT2 cell were shown in two ways such as changes in collective lipid classes 
and changes in individual lipid species. In collective lipid classes all the changes in lipid 
were presented as a fold change in percentage (%) relative to control (considered as 
100%). Major difference of the effect between DHA-FFA and DHA-nanoliposomes 
were noteworthy in the changes of DHA containing lipid classes (Figure 10 and 11).
Changes in lipidomic composition were shown in a semi-quantitative analysis using 
liquid chromatography mass spectrometry (LCMS) highlighting the variation in some 
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major phospholipids such as lysophosphatidylcholine (LPC), Phosphatidylcholine (PC), 
phosphatidylethanolamine (PE) and phosphatidylinositol (PI). 
In co-STS, almost 200% increase in all 4 lipid classes was visible in STS treated cells 
compared to control. In DHA-FFA treatment, highest variation was observed in PI 
(over 1200%) and LPC (over 1000%) where PC and PE observed with approximately
800% and 600% increased respectively. Treatment with MFGM and soy nanoliposomes 
had no major effect in altering these lipids. MFGM-DHA and Soy-DHA treatment 
shown to have almost similar effect in increasing PC and PE content to approximately
400%. Increase in the amount of LPC and PI varied from approximately 500-600% in 
both MFGM-DHA and Soy-DHA treatments (Figure 10A).
In co-H2O2, there were no noticeable changes observed in lipid profiles by H2O2, 
MFGM and soy treatments. DHA-FFA treatment was found with highest increase in PI 
to approximately 1500% where increase in LPC, PC and PE were to approximately
500%, 800% and 300% respectively.  However in MFGM-DHA and Soy-DHA 
treatments were shown to increase the PI content to around 900% and 600% 
respectively. Increase in PE was unique in both treatments (around 300%) where LPC 
and PC varied from approximately 400-500% (Figure 10B)
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Figure 10: Temporal changes of NT2 cell’s lipid classes in response to DHA-FFA, 
nanoliposomes and DHA-nanoliposomes co-treatment with (A) STS and (B) H2O2. All lipid 
species were normalized to total PC in cell, pooled together and presented in major lipid classes. 
Data presented as in percentage of fold changes relative to control (100%) in Y axis in response 
to the various treatments in X axis. 
In pre-treatment paradigm, increase in lipid classes in similar pattern but the changes 
were not as high as it was in co-treatment paradigms. In pre-STS treatment paradigm,
there were no major changes observed in alteration of the 4 lipid classes. DHA-FFA 
treatment brought about major changes in PI and LPC to around 450%-500% where 
changes in PC and PE content were to about 350%. Treatment with MFGM-DHA and 
Soy-DHA increase the PI content to approximately 350% and 250% respectively where 
the changes in PC and PE varied from approximately 200% to 250% (Figure 11A)
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Figure 11: Temporal changes of NT2 cell’s lipid classes in response to DHA-FFA, 
nanoliposomes and DHA-nanoliposomes pre-treatment following treatment with (A) STS and 
(B) H2O2. All lipid species were normalized to total PC in cell, pooled together and presented in 
major lipid classes. Data presented as in percentage of fold changes relative to control (100%) in 
Y axis in response to the various treatments in X axis. 
In pre-treatment following H2O2 exposure, increase in the LPC, PC and PI to almost 
200% compared to the control was visible in H2O2 treatment. No major changes were 
observed with MFGM and soy treatment. DHA-FFA treatment was shown to have the 
PI and LPC content increased at its highest to approximately 900% and 650% 
respectively while the PC was increased approximately 550% and PE around 300%. 
MFGM-DHA and Soy-DHA treatment showed variable increase in PI content to 
Page | 136  
 
0
100
200
300
400
500
600
Control STS DHA+STS MFGM+STS MFGM-DHA+STS SOY+STS SOY-DHA+STS
%
 o
f f
ol
d 
ch
an
ge LPC PC PE PI
0
100
200
300
400
500
600
700
800
900
1000
Control H2O2 DHA+H2O2 MFGM+H2O2 MFGM-DHA+H2O2 SOY+H2O2 SOY-DHA+H2O2
%
 o
f f
ol
d 
ch
an
ge LPC PC PE PI
A
B
approximately 470% and 540% respectively where changes in PI content was 
approximately 200-250%. Changes in LPC and PC was almost 300% in MFGM-DHA 
treatment where it was approximately 450% for Soy-DHA treatment (Figure 11B).
Changes in individual DHA containing lipid species by the DHA-FFA, nanoliposomes 
and DHA-nanoliposomes treatments were also shown. Results showed that almost all 
individual lipid species NT2 cells were increased in several folds by the treatment with 
DHA-FFA (green bars), MFGM-DHA (light blue bars) and soy-DHA (dark blue bars)
in both treatment paradigm with STS and H2O2 (Figure 12 and 13). Whereas no visible 
changes were observed with only MFGM (purple bars) and soy (orange bars) 
treatments. In all instances, the DHA-FFA treatments had higher efficacy than DHA-
nanoliposomes in increasing cellular lipid contents. Certain species of phospholipids 
that contained DHA including PI 40:6, PI 38:6, LPC 22:6, PC 16:0-22:6 and PC 40:6 
were some of the highly increased species in all treatments groups.  
 
In Co-treatment (Figure 12), the levels of increase in PLs were more than that in pre-
treatment (Figure 13). In co-STS, the overall increase in the above stated lipid species 
were 350-1250% (Figure 12A) where in pre-STS it was 250-550% (Figure 13A). On the 
other in co-H2O2, increase in PLs were 250-1550% and in pre-H2O2, it was 250-900%
relative to the control. Moreover in co-treatment, DHA-FFA supplementation was 
observed with distinctive increase in the lipid species higher than other DHA-
nanoliposomes (Figure 12). On the other hand in pre-treatment group, the effects of 
DHA-nanoliposomes particularly Soy-DHA were observed with much similar increase 
in PLs to that of DHA-FFA (Figure 13). Treatments with only nanoliposomes resulted 
without any significant effect on altering the lipid species (Figure 12 and 13)
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Figure 12: Temporal changes of NT2 cell’s phospholipid species in response to DHA-FFA, 
nanoliposomes and DHA-nanoliposomes co-treatment with (A) STS and (B) H2O2. Only the 
DHA containing lipid species were taken into consideration and normalized to total PC in cell.
Data presented as in percentage of fold changes relative to control (100%) in Y axis and lipid 
species that changed in response to various treatments in X axis. 
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Figure 13: Temporal changes of NT2 cell’s phospholipid species in response to pre-treatment 
with DHA-FFA, nanoliposomes and DHA-nanoliposomes following treatment with (A) STS 
and (B) H2O2. Only the DHA containing lipid species were taken into consideration and
normalized to total PC in cell. Data presented as in percentage of fold changes relative to 
control (100%) in Y axis and lipid species that changed in response to various treatments in X 
axis. 
4. DISCUSSION
In previous chapters of this thesis a comparative study was conducted to investigate the 
roles of different forms of DHA including DHA-FFA, DHA-PLs and other n-3 PUFAs
(DPA, EPA) in reducing cell death induced by STS and H2O2 in NT2 cells. In this 
chapter the effects of nanoliposomal DHA, free DHA and empty nanoliposomes in the 
inhibition of apoptotic cell death were measured. It was found that DHA-FFA and 
DHA-nanoliposomes have profound effect in inhibiting cells from STS and H2O2
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induced cell death in both co- and pre-treatment paradigms. Results obtained from both 
treatment paradigms with STS and H2O2 showed that apart from empty nanoliposomes, 
DHA-FFA and DHA-nanoliposomes were almost equally effective in inhibiting 
apoptotic cell death induced by STS and H2O2.
In apoptotic cells, oxidation of internal membrane phosphatidylserine (PS) results in 
translocation to the external leaflet of the plasma membrane (Ashman et al., 1995;
Fadeel & Orrenius, 2005; Fadok et al., 1992; Krahling et al., 1999; Lee et al., 2013;
Tyurina et al., 2000; Zullig et al., 2007). In the previous studies (Chapter 2 and 3), the 
protective effects of DHA-FFA against apoptosis through the accumulation of 
phosphatidylserine (PS) in cell membrane to resist cell death through 
phosphatidylinositol 3-kinase (PI3-K)/Akt pathway were explained (Akbar & Kim, 
2002; Cao et al., 2005; Garcia et al., 1998; Hamilton et al., 2000; Kim et al., 2000)
which may applicable to these observations in this study as well. Although PS was not 
detected in this particular study due to the instrumental optimization issues, there was a 
significant increase in other PLs contents by nanoliposomal DHA treatment that might 
respond in the same way as PS accumulation in the cell.
The mechanism of anti-apoptotic properties of MFGM-DHA and Soy-DHA are related 
to the structure of MFGM and soy nanoliposomes and their interaction and integration 
to the cell membrane. The presence of several PLs classes as major constituents of 
MFGM (PC, PE, PI, PS and SM) and soy (PC, PE and PI) nanoliposomes (Ambroziak 
& Cichosz, 2013; Astaire et al., 2003; Thompson et al., 2006) may give MFGM-DHA
and Soy-DHA the feasibility to be incorporated into the cell membrane and thus making 
the cell resistant to an apoptotic environment. Moreover, differences in efficiency of 
MFGM-DHA and Soy-DHA treatments in increasing lipid species may related to the 
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lipid composition of these individual nanoliposomes. There is a possibility that all these 
observation might share the same mechanism of increasing membrane lipid in reducing 
NT2 cell death which was confirmed by cytotoxicity assay using PI stain against STS 
and H2O2 induced apoptotic condition.
Previous study in neuronal cell model reported an effect of DHA-FFA treatment in 
reducing the expression of active caspase-3, which is an effector caspase, lead to 
apoptosis (Suphioglu et al., 2010). To confirm the status of apoptotic marker, western 
blot was carried out on DHA-FFA and nanoliposomal DHA-treated NT2 cells to detect 
BAX, an important pro-apoptotic marker (Cregan et al., 1999; Ichim & Tait, 2016; Tait 
& Green, 2010; Zhu et al., 2016) in this study. Reduced BAX expression by all the 
treatments in co-treatment paradigm confirms the anti-apoptotic properties of 
nanoliposomal DHA possibly by reducing the expression of active caspase-3.
In this study, lipidomic changes only in DHA containing phospholipids were shown.
There were very little or almost no changes in lipid alteration were observed in MFGM 
and soy treatment. Those characteristics may be indicative to confirm that those MFGM 
and soy nanoliposomes used in this study were pure nanoliposomes without any traces 
of DHA and unable to incorporate into the membrane to bring about any changes in 
lipid profile.
Treatment with DHA-FFA and DHA-nanoliposomes showed variable changes in 
increasing DHA containing lipid species or lipid classes compared to control in 
different treatment paradigm. Among the changes in major lipid classes including LPC, 
PC, PE and PI content, the highest increase was recorded for PI and LPC in all 
treatment paradigms. Possible reason could be the DHA act as a substrate for synthesis 
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of PI and LPC. This may be in the same way that it has previously been found that DHA 
treatment increases PS levels within the cell (Kim et al., 2000). Increase in co-treatment 
is higher than it is in pre-treatment was also a prominent observation in this study.
Possible reason was explained in previous chapter as the presence of extracellular DHA 
in the incubation medium that may supply adequate DHA into membrane phospholipid. 
Highly increased PLs in co-treatment may also justify all the previous results that 
showed better cell viability, reduced cell death and reduced BAX in all three chapters. It 
was also shown that the level of increase was higher in H2O2 treatment than that of STS
for both co and pre-treatment paradigms. Difference in apoptotic mechanism such as 
caspase activation pathway induced by STS and ROS dependent pathway induced by 
H2O2 may have contributed to these differences in activity.
DHA-FFA treatment increased DHA-containing membrane PLs more than DHA-
nanoliposomes treatment possibly due to the structural differences in the DHA-FFA and 
nanoliposomes. Nanoliposomes are internalised into cells by different mechanisms that 
may involve specific and non-specific absorption to the cells, membrane fusion, 
transfer-protein-mediated exchange of lipid components with the cell membrane and 
endocytosis (Pagano & Weinstein, 1978; Torchilin, 2005). Free diffusion may be more 
efficient in delivering free DHA to cells compared to nanoliposomal fusion. Uptake of 
nanoliposomal DHA was much slower than the free DHA might be due to the complex 
structure and lower permeability of nanoliposomes than free DHA. There were 
significant difference in the PL composition between MFGM and soy. MGFM have 
high level of sphingomyelin (SM) content than soy that lead to high degree of saturation
in fatty acid chains thus lowered permeability (Thompson et al., 2006). This may be the 
possible explanation of MFGM being not as effective as soy.
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5. CONCLUSION
Apart from MFGM, all the treatments used in this study were shown to have a potential 
effect against neuronal cell death. MFGM showed variability in its effect, which limited 
the ability to determine if the effects were reproducible. Inhibitory effect of DHA-FFA 
that has been already established in-vitro against apoptosis. Demonstration of the anti-
apoptotic properties of DHA-nanoliposomes from this study may be considered as an 
added advantage in alternative therapeutic approach against apoptotic cell death where 
applicable.
From the lipidomic study of the nanoliposomal DHA treated NT2 cells, it was clearly 
shown that DHA-FFA treatment had a greater uptake and incorporation rate into the 
cellular phospholipids than that of DHA-nanoliposomes. From these observations,
DHA-FFA demonstrated more feasible treatment option than DHA-nanoliposome in 
inhibiting neuronal cells from induced apoptosis by enhancing DHA incorporation of 
into cellular phospholipids.
There were also some differential effects of DHA-FFA versus DHA-nanoliposomes 
observed. Co-treatment showed much greater DHA-FFA uptake than DHA-
nanoliposomes. On the other hand, pre-treatment highlights that uptake of DHA-
nanoliposomes are closer to that of DHA-FFA in particular lipid such as PC. Those 
phenomena are still elusive. Experimental evidence would needed to explain those 
unique phenomena of this study.
.
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CHAPTER 5
Characterization of the effects of 
docosahexaenoic acid on neuronal cell 
activity using a microelectrode array
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ABSTRACT
Microelectrode array (MEA) has attracted paramount attention from the neuroscientific 
community to explore and understand the working principle of nervous systems and the 
effect of drugs on the behavior of neurons. In this study effort was made to explore the 
effect of docosahexaenoic acid (DHA) on the overall neuronal spike activity as well as 
the spontaneous activity patterns of primary cortical neurons employing MEA 
technology. Neocortex neurons of   C57BL/6 mice were cultured on MEA for two weeks 
until maturation and then treated with 10 μg/ml DHA for 48 hours. Results 
demonstrated that DHA supplementation enhanced overall spike activity (454.35 
spikes/Sec) of the neurons compared to the control (297.01spikes/Sec). This is a 
preliminary study to explore the changes in the electrophysiological properties of 
neurons in response to DHA supplementation. Results from this study indicated the 
potential use of DHA in improving neuronal signalling. That indicates DHA 
supplementation could be helpful in improving the diseased condition of neuronal 
disorders such as Alzheimer’s disease (AD).
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1 INTRODUCTION
In the previous chapters, it was demonstrated that DHA has a prominent effect on cell 
survival against neuronal apoptosis. It was also demonstrated that DHA exerts this 
effect through uptake by neuronal cells and incorporation into membrane phospholipids, 
which may further influence chemical and physical properties of the membrane. It also 
helps regulate cell signalling that involved in neuronal cell survival from adverse 
cellular and environmental condition, cell growth and differentiation (Kim et al., 2010).
A cascade of mechanisms are involved in this process. One of the neuroprotective 
mechanisms of DHA is through promoting the neurite outgrowth (Calderon & Kim, 
2004), which can lead to a further anti-apoptotic properties through AKT signaling 
pathway (Akbar et al., 2005). Neurite outgrowth is a process where young or 
developing neurons elongate their axon and dendritic length to form a complex circuitry 
that is essential for maintaining the homeostasis of the central nervous system (Laketa et 
al., 2007).
The effects of DHA on neuronal cell survival and neurite outgrowth were investigated 
in-vitro and in-vivo (Ahmad, Moriguchi, et al., 2002; Ahmad, Murthy, et al., 2002; Cao 
et al., 2005). A report on primary cultures of rat cortical neurons suggested that DHA 
supplementation promote neurite outgrowth and a greater immunoactivity of growth-
associated protein-43 (GAP-43). GAP-43 proteins are generally distributed in the
growth cones and used as a possible indicative marker for axonal growth (Ramakers et 
al., 1991). These experimental observations indicate DHA-stimulating neuron-specific 
protein synthesis could be a result of neurite outgrowth (Cao et al., 2005). There are few 
studies showing the effects of DHA in neuronal communication and in neuronal 
degeneration. The pathogenesis of neurodegenerative diseases includes synaptic loss 
(Lukiw et al., 2005; Stephan et al., 2012) and synaptic dysfunction a state in which
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communication through neurotransmitters is disrupted, hindering neuronal signal 
processing (Masliah, 1995; Shankar & Walsh, 2009). DHA plays a role in synaptic 
function including signal processing and cognitive abilities by providing plasma 
membrane fluidity at synaptic regions, which in turn improve neuronal signal, flow and 
improve brain function (Calderon & Kim, 2004; Gomez-Pinilla, 2008).
Action potentials or “spikes” are the common computational currency of the brain.
However, an individual neuron’s activity does not signify the cognitive and perceptual 
processes. It is more likely to be the network-level phenomena in which groups of 
neurons act in concert (Snyder et al., 2015). Numerous techniques have been developed 
to identify the activity of individual neurons and neurons as a whole in response to 
external stimuli. One of the most powerful and successful methods used for the 
recording of neural activity is extracellular recordings and stimulation by substrate-
integrated microelectrode arrays (MEAs) (Spira & Hai, 2013).
The use of MEA enables measurements of electrical activity from many excitable cells 
over periods of days and months (Hai et al., 2010; Hochberg et al., 2006) even for a 
year (Hales et al., 2010; Lewicki, 1998) making it an ideal research model to understand 
the effect of different stimulations and drugs on the neuronal connectivity. MEA for 
both in vitro and in vivo is advantageous as the extracellular recording can be performed 
without mechanical damage to the cellular plasma membrane (Hai et al., 2010; 
Johnstone et al., 2010; Nam & Wheeler, 2011) and provide a platform to understand the 
fundamentals of electrophysiology of neural network mechanisms in the brain 
(Makarova et al., 2011; McConnell et al., 2012; Pine, 1980). Accurate detection and 
localizing signatures of neural activity waveforms are essential in understanding the 
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functioning of neural networks (Biffi et al., 2010). The spikes of neural signals normally 
characterize these signatures.
Experimental use of MEA was pioneered in 1972 to record electrical activity  from 
embryonic chick heart cells on an array of 30 electrodes (Thomas et al., 1972). Later on, 
action potentials from dissociated snail ganglia were recorded by Gross and his 
associates using MEA with an array of 36 microelectrodes (Gross, 1979; Gross et al., 
1977). Use of high efficiency and high quality MEA techniques were not widely 
successful in the late 20th century although the efforts were made in cultured 
preparations of wide range of invertebrates and vertebrates (Connolly et al., 1990; Israel 
et al., 1984; Martinoia et al., 1993; Nisch et al., 1994; Novak & Wheeler, 1986, 1988; 
Regehr et al., 1989).
MEA technology platform help recording of signals from a simplified model of a 
neuronal network in the order of a single cortical column rather than a complete intact 
brain. This feature of MEA enabled me to monitor electrical signals over a defined 
period of time using a computer interface and record transient and steady state 
behaviour of the neuronal network in response to DHA supplementation. Present study 
focused on elucidating beneficial effect of DHA in neuronal signalling on mouse 
cortical neuron and revealing the neural activity in response to DHA using MEA 
technology.
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2 MATERIALS AND METHODS
2.1 Culture of acutely dissociated cortical neurons and DHA treatment
Cultures of neocortex neurons were prepared from 14-16 day gestation C57BL/6 mice. 
The corticies from embryonic mice brains were excised and then treated with 20X 
trypsin, and then manually triturated with DNase/SBTI (Sigma) that stops the action of 
the trypsin and allows a single cell suspension to be prepared. The cells were then 
centrifuged and the resulting cell pellet was then resuspended in B27 supplemented 
neurobasal medium (Gibco, Life Technologies) and plated at the required density. 
Excess cells were then frozen down in neurobasal medium supplemented with B27, 
20% foetal bovine serum and 10% DMSO, at a concentration of 10x106 cells/ml to 
ensure continuous supply throughout the experiments. Cryopreserved cortical neurons 
of mouse embryo were stored in liquid nitrogen for long-term storage. Freshly prepared 
neuronal cells were diluted with pre-warmed B27-supplemented neurobasal medium 
(Invitrogen, Germany). For the DHA treatment cells (4.0X105cells /well) were seeded 
on Poly-D-lysine coated 24 well culture plate. On 7 days in vitro (DIV 7), cells were 
treated with 10 μg/ml DHA for 48 hours leaving control cells aside. All treatments were 
done in triplicates. The picture of neurite outgrowth was captured under phase contrast 
microscope (Olympus, IX51). The cell density and viability was determined using a 
haemocytometer, allowing a stock suspension to be prepared at a density of 25,000 cells 
in a 30 μl drop of neurobasal medium (Gibco, life technology) and seeded to MEA
devices previously coated by PDL and Laminin. After DHA treatment signals from 
MEA’s were recorded.
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2.2 Immunostaining of cortical neurone for labelling of neurite
Immunostaining of cortical neurons was performed following general procedures for 
immunocytochemistry (ICC) (Abcam protocols) with some modification. Briefly, round 
coverslips rinsed in ethanol were placed inside 24well plates and coated with poly-D-
lysine (100μg/ml) for 1 hour at room temperature. Coverslip wells were rinsed with 
sterile water three times (10 min each) allowing to dry completely and sterilized them 
under UV light for at least 1 hour. Acutely dissociated cortical neurons were seeded at a 
concentration of 4×105 cells per well allowing them to grow in B27 supplemented 
neurobasal medium (Gibco, Life Technologies) for 7 days with changing the medium in 
two days interval. After 7 days, cells were treated with DHA (10μg/ml) and incubated 
for 48 hours leaving untreated controls aside. 
After the incubation medium was aspirated and cells were rinsed in phosphate-buffered 
saline (PBS) three time. Plated cells were fixed in 4% paraformaldehyde in PBS (pH 
7.4) for 10 min at room temperature. Then permeabilized by 0.1% Tinton-X on ice. 
Nonspecific labeling was blocked using 1% BSA (Sigma) and 0.2% Gelatin (Sigma) 
prior to primary antibody incubation. Plates seeded with cells were incubated overnight 
with anti-ȕ,,,7XEXOLQPRXVHPRQRFORQDODQWLERG\3URPHJD&DW*$Ln 1% BSA. 
Following three times washing with PBS cells were subsequently labeled with 
fluorescent-tagged Alexa 594 (Molecular Probe) anti-mouse secondary antibody for 1hr 
at room temperature. Cells were visualized under fluorescent microscope (Olympus 
IX51) and images were taken.
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2.3 Components and modular setup of MEA
2.3.1 MEA: A USB-MEA-System was purchased from Multichannel systems 
(MCS), Reutlingen Germany. The basic components and are listed in Table 1 and 
modular setup shown in the schematic diagram (Figure 1).The MEA chips consisted of 
a glass slide into which an array of extracellular microelectrodes were integrated. The 
insulating layer was comprised of silicon nitride (Si3N4). Typically, 10-30 μm planar 
electrodes were arranged in a square recording field. Spacing between those electrodes 
varied in a range of 30-700 μm. The electrodes were embedded in 5x5 cm glass 
substrate. 
2.3.2 Amplifier: MEA amplifier was compactly build using SMD (Surface Mounted 
Devices) technology. Raw data from 60 electrodes of a MEA) were amplified by this 
amplifier. MEA amplifiers also consist of an integrated heating element that controlled
the temperature of samples at all time. MEA with cultured sample was directly placed 
into the MEA amplifier and closed tightly.  The contact pins in the lid of the amplifier 
were pressed onto the MEA contact pads and both came to a close contact. A high 
signal-to-noise ratio was generated from the close contacting region of the amplifier to 
the MEA sensor.
2.3.3 Data acquisition: Data acquisition from the USB-MEA-System was performed 
based on signal processing technology from variable channels (60) of MEA. Respective 
to the channel numbers, single or multiple amplifiers were connected to run different 
experiments on each of them at the same time and controlled independently by data 
acquisition and analysis software “MC_Rack” at once. Integrated DSP (Digital Signal 
Processor) of the USB-MEA-System enabled them to show real-time signal detection or 
feedback. 
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Table 1: Components of MEA module.
Standard setup MEA System
Recording electrode MEA (microelectrode arrays)
Classic pattern 8 × 8 or 6 × 10 arrays of 60 channels
Electrodes Titanium nitride
Conducting layer Gold leads
Insulating layer Polyimide (or silicon nitride)
Amplifier MEA 1060 series
Connector USB-MEA60 Systems
Software MC _Rack
Electrical stimulation StimMEAs (four pairs of large 
stimulation electrodes made of titanium 
nitride)
2.3.4 Computer and software: Recorded data were analyzed by MC_Rack software 
which allows combining virtual instruments (e.g. oscilloscope, filter, event detector, 
spike sorter, sound output, or signal-triggered transistor-transistor logic “TTL” pulse).
Recorded data were then exported to external software NeuroSigX, an in-house 
software developed by a team at Institute for Intelligent Systems Research and 
Innovation (IISRI), Deakin University and individual features of processed signals were 
analyzed. 
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For the experimental model, 59 planar round electrodes were photo etched, each 
insulated from each other and coated with indium-tin oxide (ITO), palladium. One 
electrode on the edge of the array was used as ground electrode. Each other electrode 
has a 30μm diameter and 200μm center-to-center inter-electrode intervals arranged in a 
square grid (excluding corners) that covers about 0.2–2 mm. The activity of all 
experiments was recorded by means of a planar MEA60. The MEA chips were placed 
into the MEA Amplifier (Gain 1000X), and data were acquired with MC_Rack software 
(MCS) (Multi Channel Systems MCS GmbH).
Figure 1: Modular set-up of MEA. The USB-MEA-Systems consist of several components: 
MEAs, amplifier, data acquisition device, PC with software, temperature controller, as well as 
an optional perfusion cannula and peristaltic perfusion pump (Multi Channel Systems MCS 
GmbH).
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2.4 MEA Preparation
MEAs were pre-coated with poly-ethylene-imine (PEI), and laminin (Sigma Aldrich)
for improved cell attachment to the device. Laminin (0.02 mg/ml in Neurobasal 
PHGLXP ZDV DSSOLHG GLUHFWO\ WR WKH FHQWUH RI WKH DUUD\ LQ GURSV RI ȝO $IWHU
incubation, laminin drops were removed by vacuum aspiration just prior to plating cells. 
Primary neurons were allowed to rest for 30 minutes in the incubator for adhesion and 
then 1 ml of media was added in the MEA dish. Cultures were maintained in petri 
dishes with lids on, in an incubator with 5% CO2, 37°C and 65% relative humidity. The 
media was regularly changed after 4-5 days during 2 weeks of cells growth and 
maturation. 
2.5 Extracellular microelectrode recordings
On the 15-17 days in-vitro (DIVs), MEA recording was carried out after placing the 
MEA on the pre-amplifier (MCS) and heated at 37°C in a cell culture incubator (37°C, 
5% CO2, 65% relative humidity). In order to avoid contamination, culture chambers 
lids were tighten under biosafety cabinet before start recording. A high band pass digital 
filter (200 Hz) was applied to the raw signal in order to remove electrical background 
noise. Recording sessions lasted 3-5 minutes to record spontaneous signals from the 
control and treated cultures. There is a specific pathway towards the accumulation of 
signals from neuron through MEA system devices that is described in Figure 2. 
Neuronal responses from drug treatment are transformed by different parameters across 
the components of the MEA toward the recorded signal typically as a form of action 
potential (Obien et al., 2014).
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Figure 2: Diagram of MEA system stimulation and recording. The neuron is stimulated by 
the waveform generated digitally through the MEA. Modified from (Obien et al., 2014).
2.6 MEA signal analysis
Simultaneous signals from all 60 electrodes were sampled at 25 kHz, visualized and 
stored using the standard software MC-Rack provided by Multi Channel System 
(Reutlingen, Germany). Later on Spike and burst detection analysis was performed 
using specialized software NeuroSigX. Spikes detection threshold with justification: -
15μV was set to record the response from neurons cultured on MEA. 
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3 RESULTS AND DISCUSSION
3.1 DHA enhanced neurite outgrowth
Enhanced neurite growth and neuronal connections were visible under phase contrast 
microscope in DHA-treated cortical neuron cultures (Figure 3C) (marked by yellow 
arrow) compared to non-treated control cultures (Figure 3A) without increasing the 
neurite numbers which can enhance neuronal signalling. (Cao et al., 2005). Neurite 
specific Anti-ȕ,,, 7XEXOLQ PRXVH DQWLERG\ ZDV XVHG WR label neurites (red) only to 
describe the changes in the growth of neurite. It was demonstrated that DHA treatment 
increased the growth of neurite indicated by yellow arrow (Figure 3D) compared to 
untreated control cells (Figure 3B) which have less labelling of neurites than that in 
DHA-treated cultures. These results are consistent with previous observations (Calderon 
& Kim, 2004)
Figure. 3. Effect of DHA on neurite outgrowth in primary cortical neuron. Normal cell growth 
without DHA treatment is shown in (A) phase contrast microscopic view and (B) Fluorescent 
microscopic view of neuron. Visible neurite outgrowth after DHA treatment (yellow arrows)
shown in (C) phase contrast microscopic view and (D) Fluorescent microscopic view of neuron. 
Fluorescent neurons resulting from being treated with anti-ȕ ,,, WXEXOLQ DQWLERG\ FRQMXJDWHG
with Alexa 594 fluorophore (red).
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3.2 Raster analysis 
To explore the effect of DHA on the electrophysiological behaviour of the neurons, 
spike activity behaviour was analysed using spatio-temporal analysis. Figure 4 shows 
the raster plot of spatio-temporal analysis where spike activity of all 60 electrodes is 
distributed over time. Increase in the electrical signalling in between the cells will 
subsequently increase amount of dots in the raster plot, which is demonstrated in Figure
4. An increased activity in the DHA treated MEA (Figure. 4B) compared to untreated 
control (Figure 4A) was seen. This raster plot represents a particular zoomed section of 
the whole window. Each dot in the raster plot represents electrode activity over a 
specific time window.
Figure 4. Effect of DHA treatment in neuronal signalling. Neuronal signalling pattern 
presented in raster plot (A) in control and (B) DHA treated cortical neuron. Each window 
represents a particular length of recording time. 
3.3 Burst activity analysis
To further analyse the effect of DHA, quantitative spike analysis was performed 
employing activity histogram, as shown in Figure 5. An obvious increase in the spike 
activity can be observed from control to DHA treated cells. Table 2 presents estimated 
average spike rate that increases from 297.01 spikes per second to 454.35 spikes per 
second for control and DHA treated neuronal cultures, respectively. 
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Table 2: Spike rate of the control and DHA treated neuronal network
Criteria Control DHA Treated
Spike rate per second 297.01 454.35
Min spike rate per channel 393 408
Max spike rate per channel 4714 14577
Mean spike rate per channel 1485.6 2296.7
Minimum and maximum spike rate per channel and mean spike rate per channel were 
also increased in DHA treated cells compared to control cells (Table 2). These 
differences are clearly visible in Figure 5. In the control cells, the maximum spike rate 
and the mean spike rate per channel was recorded as 4714 and 1485.6 respectively 
(Figure 5A) where it was 14577 and 2296.7 for DHA treated cells (Figure 5B). This 
increased spike rate in DHA treatment clearly demonstrates the effect of DHA in 
increasing neuronal signaling.
Figure 5: Spike activity analysis of (A) control and (B) DHA treated cortical neurons on 
MEA.
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Spontaneous network burst activity behaviour was analysed to further assess the effect 
of DHA on primary cortical neurons. Network bursts are characterized by short 
transients of rapid spiking activity flanked by silent periods indicating activation 
patterns of neurons defined by rapid action potential spiking over narrow time intervals 
(Kuebler et al., 2015; Nick et al., 2013). Network bursts are common feature of the 
central nervous system used in several in vitro preparations and are considered to be 
indicators of robust neural operation, communication and neuropathology (Mack et al., 
2014). Bursts were detected based on calculating the total spiking rate which is the total 
number of spikes from all electrodes within 100 ms time bin. As a criterion of spotting 
the burst, a rapid appearance of a large number of spikes over all electrodes in a small 
(100 ms) time bin was used (Pimashkin et al., 2011).
Figure 6: Changes in spontaneous network burst activity of neuronal signalling and 
subsequent electrode activity during data recording in (A) control and (B) in DHA treated 
cortical neuron on MEA.
Burst activity analysis is shown in Figure 6, where the estimated bursts are highlighted 
with green and red lines. Green and red lines indicate the start and end of the burst 
activity with respect to time. A clear difference and improvement in bursting pattern 
from control (18 distinct burst) (Figure 6A) to DHA treated (20 distinct burst) (Figure
6B) cortical neurons is apparent. By the rate of occurrence, bursts patterns are classified 
Page | 164  
Control DHA
Nu
m
be
r o
f E
le
ct
ro
de
s
Time (ms) Time (ms)
A B
differently. Typically burst rates are relatively constant over time, apparent with either 
regular spacing indicating they are coming from normal physiological response.
Alternatively, the burst rate can be varied over the course of a recording time that can be 
highly versatile in nature (Wagenaar et al., 2006). The variability is the effect either
from the physiological changes of neuron in response to other stimuli or active response 
of the stimuli present in the system (medium). Looking into the control, it was apparent 
that the burst pattern in this experiment was more likely to be continuous (Figure 6A)
than the pattern detected in DHA-treated cells (Figure 6B) that tended to be versatile as 
per the description above. This change is bursting pattern was verified from the 
observation of spike activity analysis (Figure 5) which is a direct consequence of the 
occurrence of burst. This criteria indicates the positive effect of DHA on neuron in 
terms of signal processing.
Bursting is a general amplifying mechanism of signals from dendritic structures, 
synaptic inputs and voltage-gated channels of neurons. Any structural changes of 
neurons may bring about alterations in bursting pattern in more versatile way. It is 
acknowledged that bursting is effective at enhancing transmitter release and promoting 
synaptic ability to change their strength as a result of either their own activity as a 
consequence of activity in another pathway (Cooper, 2002). It can be suggested based 
on the results from this experiment that the changes in neurite outgrowth due to DHA 
treatment may have improved the bursting pattern.  
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3.4 Energy profile of the electrodes   
Electrode activity is measured based on the total active electrodes and their intensity of 
activity throughout out the recorded time. This activity is represented as a heat map in 
both 2D and 3D view (Figure 7). This color-coded intensity map shows the position and 
intensity of the electrical activity of a particular electrode during recording. 
The 3D view gives a vertical representation of the degree of intensity of a particular 
electrode. The data shows that the intensity of electrode activity for a particular period 
of time is almost three times higher in DHA treatment (count of 14,000) (Figure 7C)
than that of untreated control (4500 count) (Figure. 7A). From the electrode activity it
was clearly visible that DHA treatment promotes neuronal activity almost three fold 
than that of the untreated control.
Figure 7: Spontaneous electrode activity pattern of MEA’s. Results are depicted in (A) 2D
view and (B) 3D view for control. (C) 2D view and (B) 3D view for DHA supplemented 
cortical neurons on MEA.
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3.5 Burst pattern similarity variance analysis
Similarity variance between bursts were analyzed through dynamic time warping 
(DTW). DTW was developed originally for the purpose of speech recognition (Sakoe & 
Chiba, 1978; Sankoff & Kruskal, 1983). It is a technique of time series alignment 
algorithm. DTW is used to find an optimal alignment between two given (time-
dependent) sequences of feature vectors implying certain restrictions. The sequences are 
warped spontaneously in a nonlinear fashion to match each other in order to find 
similarity variance between them (Ahmed et al., 2012; Yuan et al., 2011). DTW has 
been successfully applied in the fields of data mining and information retrieval (Berndt 
& Clifford, 1994) that can automatically deal with time deformations and different 
speeds of time-dependent data . The distance between two sequences or points is 
measured by the function of Manhattan distance (absolute value of the difference). The 
Manhattan distance function of metric computes the distance that would travel to get 
from one data point to the other following a grid-like path. The distance between two 
items is the sum of the differences of their corresponding components.
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Figure 8. Dynamic time warping (DTW) of MEA recorded data. Responses are depicted as 
(A) 2D view of DTW and (B) 3D graphical distribution of variance of distances for untreated 
control cortical neuron. (C) 2D view of DTW and (D) 3D graphical distribution of variance of 
distances for DHA treated cortical neuron on MEA.
In this experiment from DTW analysis it can be seen that the similarity variance 
calculated based on Manhattan distance of detected burst has a low variance in control 
and is presented in a form of 2D bar graph (Figure 8A) featuring with narrow and 
constrict DTW bar length. Distances of variances were presented as 3D graph (Figure 
8B) along with the intensity of individual burst. On the other hand DTW from DHA 
treated samples were detected with high variance (Figure 8C) demonstrating more 
widely distributed DTW bars than that of in control. Moreover distances showing
highly diversified pattern which is noticeable with widely distributed coloured bars 
(Figure 8D). Based on the scarce information available about the similarity variance,
some researchers suggest that having wider warping window in one sample between 
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two is indicative towards more improved accuracy than the other (Berndt & Clifford, 
1994). The observed wider warping in DHA treated cortical neuron may suggest that 
the physical changes in neuron promoted by DHA treatment can bring along a variation 
in the signal processing that improves signalling patterns.
3.6 Spatio-temporal analysis
A network flow diagram is usually used to express the connective network of processed 
signal recorded from neurons cultured on MEA. Network flow describes the 
communicative pathway between connected neurons in the brain (Smith et al., 2006). In 
the following Figure 9, organized two dimensional network connectivity of signals from 
individual electrode in control was shown (Figure 9A). Green thread like structures 
represent the connective paths from one electrode to another. Bottom panel (Figure 9B)
represents the intensity of activities of the electrodes. The taller the red bars more active 
the electrodes are. Looking at the response from the DHA treated electrodes, a more 
dense and organized network activity was observed (Figure 9C and 9D) than that of the 
control (Figure 9A and 9B). This improved activity in the network flow by DHA 
treatment suggests that supplementation of DHA may have some progressive effect on 
neuron that in turn can improve the signaling mechanism of central nervous system. 
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Figure 9: Spatio-temporal analysis of network flow of MEA recorded data. Responses are 
illustrated in (A) 2D and (B) 3D view of connected electrodes for untreated control cortical 
neuron. (C) 2D and (D) 3D representation of connected electrodes for DHA treated cortical 
neuron.
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4 CONCLUSION
This study was conducted to investigate the changes in electrophysiological properties 
of neurons due to DHA treatment. Our study demonstrates a positive function of DHA 
in modulating action potential duration; affecting the information sent by one neuron 
and received by others and thus enhances neuronal signalling. Increased signalling may 
be due to an increase in neurite growth, dendritic spine density, synaptogenesis and 
synaptic membrane fluidity promoted by DHA supplementation leading increase in 
signal flow (Sakamoto et al., 2007; Tanaka et al., 2012; Wurtman, 2008). These 
phenomena were supported by the results of spike detection, burst analysis and the 
DTW function. The use of MEA is a novel approach to establish role of DHA in 
neuronal signal processing. This was a short term DHA treatment approach for primary 
neurones as used in previous the chapters. Treatment of primary cortical neurones with 
DHA for prolonged (more than 48 hrs) culture may have given us more information of 
time dependant DHA activity on neuron and explore the vast range of neuronal 
signalling pattern in response to DHA supplementation.
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This study was focused on selecting the most suitable forms of DHA for investigating 
their anti-apoptotic properties using cultured human neuronal cells as a model system.
Neuronal apoptosis is associated with several important neurological disorders,
including depression, mood disorder and even Alzheimer’s disease. The hypothesis was 
that if certain forms of DHA can be more efficiently delivered to the neuronal cells 
undergoing apoptotic stress, these may improve the health of the cell and protect them 
from the further progression of apoptosis. The aim was to find out which form of DHA 
is more effective in protecting neuronal cells from apoptosis. The data obtained from
this thesis work may contribute to the understanding how different forms of DHA can 
protect human neuronal cells against apoptosis in cultured condition.
The free fatty acid form of DHA has already been experimentally used to elucidate its 
anti-apoptotic property. It was demonstrated in the study of Neuro-2A cells that DHA 
can protect cells from staurosporine induced apoptosis. It was also shown that DHA 
enrichment promoted phosphatidylserine (PS) accumulation in the membrane 
phospholipid. This led to the activation of PI3-kinase/Akt pathway and promote
signaling pathways triggering cell survival. DHA mediated cell survival was observed 
by reduced DNA fragmentation and lowered activity of caspase-3 measured by presence 
of reduced pro-apoptotic BAX and increased anti-apoptotic BCL2 protein (Akbar et al., 
2005; Akbar & Kim, 2002; Kim. et al., 2000; Kluck et al., 1997).
Cumulative results of all studies in this thesis indicated that free fatty acid form of DHA 
was more effective in protecting cells from apoptotic cell death than any phospholipid 
DHA, other FA and nanoliposomal DHA. This may be related to differences in their
uptake mechanisms in the cell. All the n-3 FAs (DHA, DPA and EPA) used in this 
study, share close structural similarities (differing only by few carbon number and 
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double bond) but may be sufficiently different as to be further metabolized to different 
end products (Watson & De Meester, 2014) hence changing the pathway of their 
incorporation into the cells. For example, Į-linoleic acid can be desaturated and 
elongated to form long chain arachidonic acid and EPA which can be further 
metabolized to form DHA. All these metabolites has closer but considerably different 
structure. There are also substantial differences between fatty acid (FA) and 
phospholipid (PL), and nanoliposome uptake into the cells. Uptake of FA involves 
either free diffusion where the fatty acids cross the phospholipid bilayer of the 
membrane without any involvement of effector molecules. Membrane bound transport 
proteins such as fatty-acid-binding proteins (FABPs) and fatty acid transport proteins 
(FATPs) can also promote their uptake and facilitate incorporation into the cells by 
presenting them into the intracellular space of the membrane (Hamilton et al., 2002; 
Hamilton & Kamp, 1999). Whereas PLs uptake takes place either by ligand mediated 
selective or whole particle of PLs entry into the cells. Ligands are signalling molecule 
that help the target molecule bound to it and presenting to the target site equipped with 
either surface bound or intracellular receptors. Target molecules are then carried to 
the target site using internal cellular mechanism. On the other hand whole particle-
entry of phospholipids involves phospholipids uptake through selective endocytosis-
independent and protein facilitated entry pathway. Moreover, phospholipid upon their 
uptake into cell, maintain cellular homeostasis that allows healthy cellular function
which in turns regulate the uptake and incorporation of omega-3 FAs into the cell 
(Engelmann & Wiedmann, 2010).
Two nanoliposomes containing DHA (MFGM-DHA, soy-DHA) used in this study,
which have a very complex membrane structure. These are comprised of major 
phospholipid classes including phosphatidylcholine (PC), phosphatidylethanolamine 
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(PE), phosphatidylinositol (PI), phosphatidylserine (PS) and sphingomyelin (SM)
(Thompson et al., 2007; Thompson. et al., 2006). Uptake of these nanoliposomes may 
involve the mechanism of membrane diffusion to get into the cell (Kohli & Alpar, 
2004). Complex and variable membrane structure and composition may lead to 
different incorporation patterns (faster/slower) into the cell which can be the possible
cause slower uptake of nanoliposomal DHA into the cell than that of free DHA.
It was beyond the scope of the study to investigate the pathways involved in the uptake 
of each of the forms of DHA and other fatty acids. It was demonstrated that DHA 
treatment did promote more accumulation of membrane PS than other PLs treatments
which was prominent in the results from lipidomic study. But unfortunately there was
no significant PS accumulation found in the lipidomics analysis of nanoliposomal DHA 
possibly because the mass spectrometer was not optimized for the PS detection. This 
issue needs to be followed up further to obtain a PS signal. Further investigation is 
required to confirm the uptake mechanisms and pathways involved in the 
internalization of all forms of DHA used in this experiment. Lipidomic studies of 
comparative effects of free DHA, DPA, EPA and nanolipsomal DHA treatment on 
neuronal cells may be an added advantage to describe if these treatments are involved in 
PS accumulation pathway. Further study of other short chain omega-3 and even the long 
chain omega-6 fatty acids in similar treatment condition should be attempted to ensure
that the results obtained from this study is truly DHA-specific. Furthermore, in-vivo 
study of radiolabelled DHA in established animal model would be clinically useful to 
address the possible pathway of DHA incorporation into the cell as well as tracking the 
distribution of delivered DHA in the specific tissues of the body (Fu et al., 2001).
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Microelectrode array (MEA) technology was applied to characterize the 
electrophysiological properties of primary mouse cortical neurons in response to the 
DHA treatment. It was demonstrated that signalling between neurons was improved by 
DHA supplementation possibly through enhancing neurite growth (Cao et al., 2005).
Enhanced neurite growth in turns facilitates the formation and organization of neuronal 
network connections and modulate brain activity accordingly to maintain homeostasis 
of the central nervous system (CNS). This experiment dealt with short term (48 hours) 
DHA treatment. Prolonged treatment time should also be investigated to elucidate long 
term (Hales et al., 2010) effect of DHA supplementation in the neuronal cells which can 
bring about changes in signalling pattern as well. Also the effects of other omega-3 fatty 
acids and different DHA forms could be investigated on MEA.
Experimental use of DHA in past publications has been shown following pre-treatment 
of cells prior to addition of the apoptotic agents to elucidate the preventive effects 
towards a number of apoptotic and toxic agents. A different approach of co-treatment 
with DHA concurrently with the apoptosis inducing agents in neuronal model cell 
(NT2) culture system was introduced in this study. Cumulative results from treatments 
of various forms of DHA in co- and pre-treatment paradigms in apoptotic condition 
indicated that the free fatty acid form of DHA was more effective in protecting cells 
from apoptotic cell death than any other forms of DHA or other FA, which proves the 
postulated hypothesis to be true. It was also found that co-treatment of DHA had higher 
potential in protecting cells from induced apoptotic cell death thus improving cell 
viability. This inhibitory ability of DHA in co-treatment may suggest that in clinical 
settings, free DHA may be effective as a treatment option for the cells that are already 
in diseased state and can effectively reduce the severity of the prevailing diseased
condition.
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Taken together, data presented in this thesis may contribute to the clinical 
understanding and formulation of appropriate form of DHA supplementation for the 
diseased neurological conditions that could reduce the burden of several neurological 
and neurodegenerative disorders.
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